<SEC-DOCUMENT>0001104659-25-103157.txt : 20251028
<SEC-HEADER>0001104659-25-103157.hdr.sgml : 20251028
<ACCEPTANCE-DATETIME>20251028160521
ACCESSION NUMBER:		0001104659-25-103157
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251028
DATE AS OF CHANGE:		20251028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Datavault AI Inc.
		CENTRAL INDEX KEY:			0001682149
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				301135279
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288538
		FILM NUMBER:		251424785

	BUSINESS ADDRESS:	
		STREET 1:		15268 NW GREENBRIER PKWY
		CITY:			BEAVERTON
		STATE:			OR
		ZIP:			97006
		BUSINESS PHONE:		408-627-4716

	MAIL ADDRESS:	
		STREET 1:		15268 NW GREENBRIER PKWY
		CITY:			BEAVERTON
		STATE:			OR
		ZIP:			97006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WISA TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20220311

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Wireless Technologies, Inc.
		DATE OF NAME CHANGE:	20180914

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Semiconductor Inc.
		DATE OF NAME CHANGE:	20180501
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>tm2529329d1_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule&nbsp;424(b)(5)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No.&nbsp;333-288538</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prospectus Supplement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(to Prospectus dated July&nbsp;9, 2025)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5,725,907 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2529329d1_424b5img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are offering 5,725,907 shares (the &ldquo;Shares&rdquo;)
of our common stock, par value $0.0001 per share (the &ldquo;Common Stock&rdquo;), pursuant to this prospectus supplement and the accompanying
prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into a securities purchase agreement
(the &ldquo;Purchase Agreement&rdquo;), dated October&nbsp;24, 2025, with the purchasers party thereto (the &ldquo;Purchasers&rdquo;),
relating to the issuance of the Shares. The aggregate purchase price for the Shares is $2,500,000. The per share purchase price for the
Initial Shares (as defined below) is $0.34 and the per share purchase price for the Additional Shares (as defined below) is $0.47.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance of the Shares will be undertaken in two separate closings.
On the initial closing date (the &ldquo;Initial Closing Date&rdquo;), which is expected to be on or about October&nbsp;29, 2025, the Company
will issue 1,470,588 shares (the &ldquo;Initial Shares&rdquo;) of Common Stock (the &ldquo;Initial Closing&rdquo;). The Company is expected
to issue (the &ldquo;Additional Closing&rdquo; and such date, the &ldquo;Additional Closing Date&rdquo; and together with the Initial
Closing Date, each a &ldquo;Closing Date&rdquo;) to the Purchasers 4,255,319 shares (the &ldquo;Additional Shares&rdquo;) of Common Stock
on the business day immediately after it obtains the approval by the stockholders of the Company of an amendment to the Company&rsquo;s
certificate of incorporation increasing the number of shares of Common Stock authorized for issuance to an amount sufficient to satisfy
the Company&rsquo;s existing contractual obligations (the &ldquo;Stockholder Approval&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is listed on the Nasdaq Capital
Market, under the symbol &ldquo;DVLT&rdquo;. On October&nbsp;23, 2025, the last reported sale price of our Common Stock on the Nasdaq
Capital Market was $$2.25 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves a high
degree of risk. Before buying any of our securities, you should carefully read &ldquo;Risk Factors&rdquo; on page&nbsp;S-4 of this prospectus
supplement, on page&nbsp;4 of the accompanying prospectus, and under similar headings in the other documents that are incorporated by
reference into this prospectus supplement and the accompanying prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement and the
accompanying prospectus are truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Delivery of the Initial Shares being offered pursuant to this prospectus
supplement and the accompanying prospectus is expected to be made on or about October&nbsp;29, 2025, subject to the satisfaction of certain
closing conditions. Delivery of the Additional Shares being offered pursuant to this prospectus supplement and the accompanying prospectus
is expected to be made on or about the business day immediately after the date Stockholder Approval is obtained, subject to the satisfaction
of certain closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus supplement is October&nbsp;24,
2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prospectus Supplement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; width: 93%"><A HREF="#b_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS
    PROSPECTUS SUPPLEMENT</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 6%; text-align: center"><A HREF="#b_001">S-ii</A></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL NOTE REGARDING
    FORWARD LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_002">S-iii</A></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUPPLEMENT
    SUMMARY</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></A></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE OFFERING</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-3</FONT></A></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</FONT></A></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-7</FONT></A></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DILUTION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></A></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SECURITIES
    THAT WE ARE OFFERING</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-9</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-10</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-11</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-11</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE
    INFORMATION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-11</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><A HREF="#b_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF CERTAIN
    DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="#b_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-12</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 95%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL NOTE REGARDING FORWARD-LOOKING
    STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE SECURITIES WE MAY&nbsp;OFFER</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF RIGHTS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>No dealer, salesperson or other person is
authorized to give any information or to represent anything not contained in this prospectus supplement or the accompanying prospectus.
You must not rely on any unauthorized information or representations. This prospectus supplement and the accompanying prospectus are
an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The
information contained in this prospectus supplement and the accompanying prospectus is current only as of their respective dates.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_001"></A><B>ABOUT THIS PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have filed with the U.S. Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) a registration statement on Form&nbsp;S-3 (File No.&nbsp;333-288538) utilizing a shelf registration
process relating to the securities described in this prospectus supplement, which registration statement was declared effective on July&nbsp;9,
2025. Under this shelf registration process, we may, from time to time, sell up to $250 million in the aggregate of shares of Common
Stock, shares of preferred stock, debt securities, warrants, rights or units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This document consists of two parts. The first
part is the prospectus supplement, including the documents incorporated by reference herein, which describes the specific terms of this
offering. The second part, the accompanying prospectus, including the documents incorporated by reference therein, provides more general
information. In general, when we refer only to the prospectus, we are referring to both parts of this document combined. Before you invest,
you should carefully read this prospectus supplement, the accompanying prospectus, all information incorporated by reference herein and
therein, as well as the additional information described under the heading &ldquo;Where You Can Find More Information.&rdquo; These documents
contain information you should carefully consider when deciding whether to invest in our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus supplement may add, update or
change information contained in the accompanying prospectus. To the extent there is a conflict between the information contained in this
prospectus supplement and the accompanying prospectus, you should rely on information contained in this prospectus supplement, provided
that if any statement in, or incorporated by reference into, one of these documents is inconsistent with a statement in another document
having a later date, the statement in the document having the later date modifies or supersedes the earlier statement. Any statement
so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed
not to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should rely only on the information contained
in this prospectus supplement, the accompanying prospectus, any document incorporated by reference herein or therein, or any free writing
prospectuses we may provide to you in connection with this offering. We have not authorized anyone to provide you with any different
information. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others
may provide to you. The information contained in this prospectus supplement, the accompanying prospectus, and in the documents incorporated
by reference herein or therein is accurate only as of the date such information is presented. Our business, financial condition, results
of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus supplement and the accompanying
prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the securities to which
it relates, nor do this prospectus supplement and the accompanying prospectus constitute an offer to sell or the solicitation of an offer
to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities offered pursuant to the registration
statement to which this prospectus supplement relates may only be offered and sold if not more than three years have elapsed since July&nbsp;9,
2025, the initial effective date of the registration statement, subject to the extension of this period in compliance with applicable
SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference herein were made
solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties
to such agreement, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties
or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied
on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless the context indicates otherwise, as used
in this prospectus supplement, the terms &ldquo;Datavault,&rdquo; &ldquo;DVLT,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo;
and &ldquo;our&rdquo; refer to Datavault AI&nbsp;Inc. and its subsidiaries on a consolidated basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_002"></A><B>SPECIAL NOTE REGARDING
FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus supplement, the accompanying
prospectus and the documents incorporated by reference herein and therein, including the sections entitled &ldquo;Risk Factors&rdquo;,
contain &ldquo;forward-looking statements&rdquo; within the meaning of Section&nbsp;21(E)&nbsp;of the Securities Exchange Act of 1934,
as amended (the &ldquo;Exchange Act&rdquo;), and Section&nbsp;27A of the Securities Act. These forward-looking statements include, without
limitation: statements regarding proposed new products or services; statements concerning litigation or other matters; statements concerning
projections, predictions, expectations, estimates or forecasts for our business, financial and operating results and future economic
performance; statements of our management&rsquo;s goals and objectives; statements concerning our competitive environment, availability
of resources and regulation; trends affecting our financial condition, results of operations or future prospects; our financing plans
or growth strategies; and other similar expressions concerning matters that are not historical facts. Words such as &ldquo;may&rdquo;,
 &ldquo;will&rdquo;, &ldquo;should&rdquo;, &ldquo;could&rdquo;, &ldquo;would&rdquo;, &ldquo;predicts&rdquo;, &ldquo;potential&rdquo;,
 &ldquo;continue&rdquo;, &ldquo;expects&rdquo;, &ldquo;anticipates&rdquo;, &ldquo;future&rdquo;, &ldquo;intends&rdquo;, &ldquo;plans&rdquo;,
 &ldquo;believes&rdquo; and &ldquo;estimates,&rdquo; and variations of such terms or similar expressions, are intended to identify such
forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements should not be read
as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which, that performance
or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or our
management&rsquo;s good faith belief as of that time with respect to future events. Our actual results may differ materially from those
expressed in, or implied by, the forward-looking statements due to a number of factors including, but not limited to, those set forth
under the heading &ldquo;Risk Factors&rdquo; in this prospectus supplement and the accompanying prospectus, as well as other risks discussed
in documents that we file with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements speak only as of the
date they are made. You should not put undue reliance on any forward-looking statements. We assume no obligation to update forward-looking
statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except
to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be
drawn that we will make additional updates with respect to those or other forward-looking statements. You should review our subsequent
reports filed with the SEC described in the sections of this prospectus supplement and the accompanying prospectus entitled &ldquo;Where
You Can Find More Information&rdquo; and &ldquo;Incorporation of Certain Documents by Reference,&rdquo; all of which are accessible on
the SEC&rsquo;s website at <I>www.sec.gov</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDUSTRY AND MARKET DATA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, information contained
in this prospectus supplement and the accompanying prospectus concerning our industry and the market in which we operate, including our
market position, market opportunity and market size, is based on information from various sources, on assumptions that we have made based
on such data and other similar sources and on our knowledge of the markets for our products. These data sources involve a number of assumptions
and limitations, and you are cautioned not to give undue weight to such estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not independently verified any third-party
information. While we believe the market position, market opportunity and market size information included in this prospectus supplement
and the accompanying prospectus is generally reliable, such information may be imprecise. In addition, projections, assumptions and estimates
of our future performance and the future performance of the industry in which we operate is necessarily subject to a high degree of uncertainty
and risk due to a variety of factors, including those described in the section titled &ldquo;Risk Factors&rdquo; and elsewhere in this
prospectus supplement. These and other factors could cause results to differ materially from those expressed in the estimates made by
the independent parties and by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="border: Black 1pt solid; padding-right: 5pt; padding-left: 5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_003"></A><B>PROSPECTUS SUPPLEMENT SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This summary highlights selected information
about the Company, this offering and information appearing elsewhere in this prospectus supplement, in the accompanying prospectus, and
in the documents we incorporate by reference. This summary is not complete and does not contain all the information that you should consider
before investing in our securities. You should read this entire prospectus supplement and the accompanying prospectus carefully, including
the &ldquo;Risk Factors&rdquo; contained in this prospectus supplement beginning on page&nbsp;S-3, and the risk factors, financial statements
and notes incorporated by reference herein, before making an investment decision. This prospectus supplement may add to, update or change
information in the accompanying prospectus.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We were formed as a Delaware limited liability
company on July&nbsp;23, 2010 and converted into a Delaware corporation, effective December&nbsp;31, 2017. Effective as of March&nbsp;11,
2022, we changed our name to WiSA Technologies,&nbsp;Inc. On December&nbsp;31, 2024, we purchased certain intellectual property assets
from EOS Technology Holdings Inc., followed by changing our name to Datavault AI Inc. on February&nbsp;13, 2025. As we expand the business
in the future with the assets from this acquisition, we plan to focus on data management and monetization, as well as continuing to use
wireless audio to transmit data and audio for consumer use and will solidify our position as an innovative leader in next-generation
data technology. Datavault AI stands at the forefront of innovation, delivering cutting-edge Web 3.0 data management and high-performance
computing (HPC) solutions to a global audience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Datavault AI is a pioneering technology licensing
company that owns a portfolio of patented, secure platforms designed to redefine how data is managed, valued, and monetized in the modern
era. Leveraging our proprietary HPC capabilities and advanced software, we aim to empower future customers worldwide with revolutionary
data solutions. Once the acquired intellectual property assets are fully integrated and a revenue stream is established, we expect that
the heart of our offerings will be our artificial intelligence (AI)-driven agents&mdash;branded as Data Vault&reg;, DataValue&reg;, DataScore&reg;,
and Data Vault Bank&reg;. These tools harness generative AI to deliver enterprise-grade data management solutions tailored for the HPC
landscape and the Web 3.0 paradigm. Our technology ensures data ownership immutability, experiential data observability, precise data
asset valuation, and secure monetization&mdash;which we believe will unlock unprecedented opportunities for businesses in an increasingly
data-driven world on which our executive leadership, with our engineering and software development teams, can capitalize. Datavault AI
has two synergistic platforms (Data Science and Acoustic Science) that plan to optimize the revenue generation of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Data Sciences Platform will be anchored by
our flagship Data Vault&reg; platform&mdash;a patented, cyber-secure asset tokenization platform that sets a new standard for trust and
innovation in Web 3.0 data science. Central to this platform are our industry-first Sumerian&reg; crypto-anchors, which will be able
to empower future customers to verify, validate, and monetize both physical and digital assets with confidence. We believe this groundbreaking
technology will enable future customers to seamlessly track and monetize historical, current, and future data tied to any asset, integrating
effortlessly with existing systems. By layering blockchain and AI-driven metadata atop diverse data sources, Data Vault&reg; plans to
provide licensees with a framework for indexing, valuing, scoring, and monetizing assets in immersive 2D and 3D experiential environments.
Complementing this, our patented Information Data Exchange&reg; (IDE) will offer a secure, privacy-compliant marketplace where tokenized
data and assets can be marketed, bought, and sold directly between owners and buyers. This division will enable enterprises to unlock
the full potential of their data assets and provide the ability to turn data from a cost center into cash that can enrich their balance
sheets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Products and services of Datavault AI&rsquo;s
Data Sciences Platform, which we anticipate will be significant revenue generators in the future, include Data Vault&reg;&mdash;our multi-patented
Web 3.0 data perception, visualization, valuation&nbsp;&amp; monetization software platform for high performance computing. Data Vault
will be monetized through licensing and software as a services (SaaS) contracts. AI driven agents will be used within Data Vault to create
new data assets and valuable insights for Datavault AI&rsquo;s future customers in the data and AI space. DataScore, DataValue, and Digital
Twin Institute are Data Vault outputs that will be able to be monetized through revenue splits with future Datavault AI customers. Our
technology creates connections for our customers to their decentralized blockchains with capacity to connect to any qualified chain and
the ability to create proprietary new blockchains for our future licensed customers. Data Vault integrates data sets, mints digital assets
on any blockchain and provides industry first crypto anchors, metadata asset indexing, blockchain tokenization systems management, data
ownership monetization with Data Vault Bank automated smart contract production, VerifyU&mdash;our academic accreditation system, asset
tokenization, name image likeness (NIL) monetization,&nbsp;Information Data Exchange&reg;, encrypted data monetization, tokenized data
and assets, each of which are easily tracked and will be easily monetized, all within the IDE, in one cohesive platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1pt solid"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Our Acoustic Sciences Platform now features
a fusion of WiSA&rsquo;s proven and wireless standard technology and the category creating ADIO inaudible tone, data over sound, and
mobile quick response technology. ADIO technology was acquired with plans to enhance the revenue production and productization of
WiSA E technology. Prior to the acquisition of IP assets from EOS Technology Holdings Inc., we had established a leadership position
in audio innovation within high-definition wireless audio transmission technology. These multi-patented spatial and multichannel HD
sound transmission technologies&mdash;including intellectual property covering audio timing, synchronization, and multi-channel
Interference Cancellation&mdash;will integrate with the Adio technology we acquired in the acquisition. Adio is a set of IP
pioneering data-over-sound, sonic anchor, and inaudible tone transmission and receiver technologies. Together, these capabilities
create a powerful synergy, blending the extensive intellectual property portfolio that we recently acquired with WiSA&rsquo;s legacy
audio solutions. We believe this collaboration will deliver transformative value across multiple markets, including sports and
entertainment, education, retail, commercial, government, and scientific sectors. By combining these exclusive patented
technologies, we will not only enhance current and future customer experiences but also plan to redefine how data and sound converge
can drive business success. Datavault AI is a pioneering technology licensing company that owns a portfolio of patented, secure
platforms designed to redefine how data is managed, valued, and monetized in the modern era. Leveraging our proprietary HPC
capabilities and advanced software, we aim to empower customers worldwide with revolutionary data solutions. At the heart of our
offerings are our artificial intelligence (AI)-driven agents&mdash;branded as Data Vault&reg;, DataValue&reg;, DataScore&reg;, and
Data Vault Bank&reg;. These tools harness generative AI to deliver enterprise-grade data management solutions tailored for the HPC
landscape and the Web 3.0 paradigm. Our technology ensures data ownership immutability, experiential data observability, precise
data asset valuation, and secure monetization&mdash;which we believe will unlock unprecedented opportunities for businesses in an
increasingly data-driven world on which our executive leadership, with our engineering and software development teams, can
capitalize. Datavault AI has two synergistic platforms (Data Science and Acoustic Science) that plan to optimize the revenue
generation of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Data Sciences Platform is anchored by our
flagship Data Vault&reg; platform&mdash;a patented, cyber-secure asset tokenization platform that sets a new standard for trust and innovation
in Web 3.0 data science. Central to this platform are our industry-first Sumerian&reg; crypto-anchors, which empower customers to verify,
validate, and monetize both physical and digital assets with confidence. This groundbreaking technology enables the seamless tracking
and monetization of historical, current, and future data tied to any asset, integrating effortlessly with existing systems. By layering
blockchain and AI-driven metadata atop diverse data sources, Data Vault&reg; plans to provide licensees with a framework for indexing,
valuing, scoring, and monetizing assets in immersive 2D and 3D experiential environments. Complementing this, our patented Information
Data Exchange&reg; (IDE) offers a secure, privacy-compliant marketplace where tokenized data and assets can be marketed, bought, and
sold directly between owners and buyers. This division will enable enterprises to unlock the full potential of their data assets and
provide the ability to turn data from a cost center into cash that can enrich their balance sheets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue producing products and services of Datavault
AI&rsquo;s Data Sciences Platform include Data Vault&reg;&mdash;our multi-patented Web 3.0 data perception, visualization, valuation&nbsp;&amp;
monetization software platform for high performance computing. Data Vault is monetized through licensing and software as a services (SaaS)
contracts. AI driven agents are used within Data Vault to create new data assets and valuable insights for our Datavault AI customers.
DataScore, DataValue, and Digital Twin Institute are Data Vault outputs that are monetized through revenue splits with Datavault AI customers.
Our technology creates connections for our customers to their decentralized blockchains with capacity to connect to any qualified chain
and the ability to create proprietary new blockchains for our licensed customers. Data Vault integrates data sets, mints digital assets
on any blockchain and provides industry first crypto anchors, metadata asset indexing, blockchain tokenization systems management, data
ownership monetization with Data Vault Bank automated smart contract production, VerifyU&mdash;our academic accreditation system, asset
tokenization, name image likeness (NIL) monetization,&nbsp;Information Data Exchange&reg;, encrypted data monetization, tokenized data
and assets, each of which are easily tracked and monetized, all within the IDE, in one cohesive platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Acoustic Sciences Platform now features a
fusion of WiSA&rsquo;s proven and wireless standard technology and the category creating ADIO inaudible tone, data over sound, and mobile
quick response technology. ADIO technology was acquired to enhance the revenue production and productization of WiSA E technology. Prior
to the acquisition of IP assets from Data Vault Holdings Inc., we had established a leadership position in audio innovation within high-definition
wireless audio transmission technology. These multi-patented spatial and multichannel HD sound transmission technologies&mdash;including
intellectual property covering audio timing, synchronization, and multi-channel Interference Cancellation&mdash;integrate with the Adio
technology we acquired in the acquisition. Adio is a set of IP pioneering data-over-sound, sonic anchor, and inaudible tone transmission
and receiver technologies. Together, these capabilities create a powerful synergy, blending the extensive intellectual property portfolio
that we recently acquired with WiSA&rsquo;s legacy audio solutions. We believe this collaboration will deliver transformative value across
multiple markets, including sports and entertainment, education, retail, commercial, government, and scientific sectors. By combining
these exclusive patented technologies, we are not only enhancing customer experiences but also redefining how data and sound converge
to drive business success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_004"></A><B>THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%"><FONT STYLE="font-size: 10pt">Shares of Common Stock offered by us</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 82%; text-align: justify"><FONT STYLE="font-size: 10pt">5,725,907 shares of common stock. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Offering price per share of Common Stock </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$0.34 for the Initial Shares and $0.47 of the Additional Shares </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Shares of Common Stock outstanding immediately before this offering</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">284,716,319 <SUP>(1)</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Shares of Common Stock outstanding immediately after this offering</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">290,442,226&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Use of proceeds</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">We estimate that the net proceeds from this offering will be approximately $2,450,000, after deducting estimated offering expenses payable by us. We intend to use the net proceeds of this offering to (i)&nbsp;make required payment under the EOS Note (as defined in the section under the heading &ldquo;Use of Proceeds&rdquo;), (ii)&nbsp;make required payment under the CSI Notes (as defined in the section under the heading &ldquo;Use of Proceeds&rdquo;) and (iii)&nbsp;accelerate the Company&rsquo;s supercomputing infrastructure, expand independent data exchanges and for working capital and other general corporate purposes. See &ldquo;Use of Proceeds&rdquo; on page&nbsp;S-7 of this prospectus supplement.&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Risk factors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">An investment in our securities involves substantial risks. You should read carefully the &ldquo;Risk Factors&rdquo; on page&nbsp;S-4 of this prospectus supplement, on page&nbsp;4 of the accompanying prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Nasdaq symbol for Common Stock</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&ldquo;DVLT&rdquo;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of
    Common Stock that will be outstanding immediately before this offering and to be outstanding after this offering is based on 284,716,319
    shares of Common Stock outstanding as of October&nbsp;17, 2025, but excludes the following as of such date: (i)&nbsp;1,150,012 restricted
    stock units (&ldquo;RSUs&rdquo;) that have been issued but have not vested, all of which have been deferred pursuant to agreement
    by holders of such RSUs, (ii)&nbsp;11,528,822 shares of Common Stock issuable pursuant to convertible notes issued on May&nbsp;20,
    2025, to CompuSystems,&nbsp;Inc., (iii)&nbsp;4,675,857 shares of Common Stock issuable pursuant to the EOS Note, all of which has
    been deferred pursuant to an agreement by the holder of the EOS Note, and (iv)&nbsp;2,750,000 shares of Common Stock issuable pursuant
    to an agreement between the Company and NYIAX,&nbsp;Inc. (&ldquo;NYIAX&rdquo;), all of which has been deferred as agreed by NYIAX.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_005"></A><B>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Investing in our securities involves a high
degree of risk. You should carefully consider and evaluate all of the information contained in this prospectus supplement, the accompanying
prospectus and in the documents that we incorporate by reference into this prospectus supplement and the accompanying prospectus before
you decide to accept any securities offered hereby. In particular, you should carefully consider and evaluate the risks and uncertainties
described under the heading &ldquo;Risk Factors&rdquo; in this prospectus supplement and the accompanying prospectus, or in the documents
incorporated by reference herein and therein. Any of the risks and uncertainties set forth in this prospectus supplement and the accompanying
prospectus, as updated by annual, quarterly and other reports and documents that we file with the SEC and incorporate by reference into
this prospectus supplement or the accompanying prospectus, could materially and adversely affect our business, results of operations
and financial condition, which in turn could materially and adversely affect the value of our securities.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to this Offering and Ownership of Our Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We will have broad discretion as to the use of the proceeds
from this offering, and we may not use the proceeds effectively.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to use the net proceeds from this offering,
after making payments under our existing contractual obligations, to accelerate the Company&rsquo;s supercomputing infrastructure, expand
independent data exchanges and for working capital and other general corporate purposes. We have considerable discretion in the application
of the net proceeds of this offering. You will not have the opportunity, as part of your investment decision, to assess whether such
proceeds are being used in a manner agreeable to you. You must rely on our judgment regarding the application of the net proceeds of
this offering, which may be used for corporate purposes that do not improve our profitability or increase the price of our shares of
Common Stock. Such proceeds may also be placed in investments that do not produce income or that lose value. The failure to use such
funds by us effectively could have a material adverse effect on our business, financial condition, operating results and cash flow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The market price for our Common Stock is
particularly volatile given our status as a relatively unknown company with a small and thinly traded public float, and lack of profits,
which could lead to wide fluctuations in our share price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for our Common Stock is characterized
by significant price volatility when compared to the shares of larger, more established companies that have large public floats, and we
expect that our share price will continue to be more volatile than the shares of such larger, more established companies for the indefinite
future, although such fluctuations may not reflect a material change to our financial condition or operations during any such period.
Such volatility can be attributable to a number of factors. For example, from January&nbsp;1, 2021 through December&nbsp;31, 2021 the
reported sale price of our Common Stock fluctuated between $18,890.55 and $73,163.42 per share. From January&nbsp;1, 2022 through December&nbsp;31,
2022 the reported sale price of our Common Stock fluctuated between $1,293.85 and $21,139.43 per share. From January&nbsp;1, 2023 through
December&nbsp;31, 2023 the reported closing price of our Common Stock has fluctuated between $15.95 and $2,400.30 per share. From January&nbsp;1,
2024 through December&nbsp;31, 2024, the reported sale price of our Common Stock fluctuated between $1.15 and $18.10 per share. From January&nbsp;1,
2025 through October&nbsp;23, 2025, the reported sale price of our Common Stock fluctuated between $0.28 and $2.53 per share. Such volatility
can be attributable to a number of factors. First, as noted above, our Common Stock is, compared to the shares of such larger, more established
companies, sporadically and thinly traded. The price for our Common Stock could, for example, decline precipitously in the event that
a large number of our shares are sold on the market without commensurate demand. Secondly, we are a speculative or &ldquo;risky&rdquo;
investment due to our lack of profits to date. As a consequence of this enhanced risk, more risk-adverse investors may, under the fear
of losing all or most of their investment in the event of negative news or lack of progress, be more inclined to sell their shares on
the market more quickly and at greater discounts than would be the case with the stock of a larger, more established company that has
a large public float. Many of these factors are beyond our control and may decrease the market price of our Common Stock regardless of
our operating performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to being highly volatile, our Common
Stock could be subject to wide fluctuations in response to a number of factors that are beyond our control, including, but not limited
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations in our revenues and operating expenses;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated changes
    in the estimates of our operating results or changes in stock market analyst recommendations regarding our Common Stock, other comparable
    companies or our industry generally;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market conditions in our industry, the industries of
    our customers and the economy as a whole;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or expected changes in our growth rates or our
    competitors&rsquo; growth rates;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments in the financial markets and worldwide
    or regional economies;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements of innovations or new products or services
    by us or our competitors;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements by the government relating to regulations
    that govern our industry;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales of our Common Stock or other securities by us
    or in the open market;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in the market valuations of other comparable
    companies; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other events or factors,
    many of which are beyond our control, including those resulting from such events, or the prospect of such events, including war,
    terrorism and other international conflicts, public health issues including health epidemics or pandemics, such as the COVID-19 pandemic,
    and natural disasters such as fire, hurricanes, earthquakes, tornados or other adverse weather and climate conditions, whether occurring
    in the United States or elsewhere, could disrupt our operations, disrupt the operations of our suppliers or result in political or
    economic instability.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if the market for technology stocks
or the stock market in general experiences loss of investor confidence, the trading price of our Common Stock could decline for reasons
unrelated to our business, financial condition or operating results. The trading price of our Common Stock could also decline in reaction
to events that affect other companies in our industry, even if these events do not directly affect us. Each of these factors, among others,
could harm the value of our Common Stock. In the past, following periods of volatility in the market, securities class-action litigation
has often been instituted against companies. Such litigation, if instituted against us, could result in substantial costs and diversion
of management&rsquo;s attention and resources, which could materially and adversely affect our business, operating results and financial
condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If securities or industry analysts do not
publish research or reports about our business, or publish negative reports about our business, our Common Stock price and trading volume
could decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading market for our Common Stock may depend
in part on the research and reports that securities or industry analysts may publish about us or our business, our market and our competitors.
We do not have any control over such analysts. If one or more such analysts downgrade or publish a negative opinion of our Common Stock,
the Common Stock price would likely decline. If analysts do not cover us or do not regularly publish reports on us, we may not be able
to attain visibility in the financial markets, which could have a negative impact on our Common Stock price or trading volume.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>In the event that our Common Stock is delisted
from Nasdaq, U.S. broker-dealers may be discouraged from effecting transactions in shares of our Common Stock because they may be considered
penny stocks and thus be subject to the penny stock rules.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC has adopted a number of rules&nbsp;to
regulate &ldquo;penny stock&rdquo; that restricts transactions involving stock which is deemed to be penny stock. Such rules&nbsp;include
Rules&nbsp;3a51-1, 15g-1, 15g-2, 15g-3, 15g-4, 15g-5, 15g-6, 15g-7, and 15g-9 under the Securities Exchange Act of 1934, as amended.
These rules&nbsp;may have the effect of reducing the liquidity of penny stocks. &ldquo;Penny stocks&rdquo; generally are equity securities
with a price of less than $5.00 per share (other than securities registered on certain national securities exchanges or quoted on Nasdaq
if current price and volume information with respect to transactions in such securities is provided by the exchange or system). Our shares
of Common Stock have in the past constituted, and may again in the future constitute, &ldquo;penny stock&rdquo; within the meaning of
the rules. The additional sales practice and disclosure requirements imposed upon U.S. broker-dealers for sales of penny stocks may discourage
such broker-dealers from effecting transactions in shares of our Common Stock, which could severely limit the market liquidity of such
shares of Common Stock and impede their sale in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A U.S. broker-dealer selling penny stock to anyone
other than an established customer or &ldquo;accredited investor&rdquo; (generally, an individual with a net worth in excess of $1,000,000
or an annual income exceeding $200,000, or $300,000 together with his or her spouse) must make a special suitability determination for
the purchaser and must receive the purchaser&rsquo;s written consent to the transaction prior to sale, unless the broker-dealer or the
transaction is otherwise exempt. In addition, the &ldquo;penny stock&rdquo; regulations require the U.S. broker-dealer to deliver, prior
to any transaction involving a &ldquo;penny stock&rdquo;, a disclosure schedule prepared in accordance with SEC standards relating to
the &ldquo;penny stock&rdquo; market, unless the broker-dealer or the transaction is otherwise exempt. A U.S. broker-dealer is also required
to disclose commissions payable to the U.S. broker-dealer and the registered representative and current quotations for the securities.
Finally, a U.S. broker-dealer is required to submit monthly statements disclosing recent price information with respect to the &ldquo;penny
stock&rdquo; held in a customer&rsquo;s account and information with respect to the limited market in &ldquo;penny stocks&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders should be aware that, according
to the SEC, the market for &ldquo;penny stocks&rdquo; has suffered in recent years from patterns of fraud and abuse. Such patterns include
(i)&nbsp;control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii)&nbsp;manipulation
of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii)&nbsp;&ldquo;boiler room&rdquo;
practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (iv)&nbsp;excessive
and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v)&nbsp;the wholesale dumping of the same securities
by promoters and broker-dealers after prices have been manipulated to a desired level, resulting in investor losses. Our management is
aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate
the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical
limitations to prevent the described patterns from being established with respect to our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You will experience immediate and substantial
dilution in the net tangible book value per share of our common stock sold in this offering and may experience additional dilution of
your investment in the future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effective price per share of common stock
sold in this offering is substantially higher than the pro forma net tangible book value per share of our common stock outstanding prior
to this offering. You will suffer immediate and substantial dilution of $0.43 per share, with respect to the pro forma net tangible book
value of our common stock as of June&nbsp;30, 2025. See the section titled &ldquo;Dilution&rdquo; below for a more detailed discussion
of the dilution you will incur if you purchase securities in this offering. Further, because we may need to raise additional capital to
fund our anticipated level of operations, we may in the future sell substantial amounts of common stock or securities convertible into
or exchangeable for common stock. These future issuances of equity or equity-linked securities, together with the exercise or conversion
of outstanding options, warrants, notes and/or any additional shares issued in connection with acquisitions, if any, will likely result
in further dilution to investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You may experience future dilution as a
result of future equity offerings and other issuances of our Common Stock or other securities. In addition, this offering and future
equity offerings and other issuances of our Common Stock or other securities may adversely affect our Common Stock price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to raise additional capital, we may
in the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock at
prices that may not be the same as the price per share in this offering. We may not be able to sell shares or other securities in any
other offering at a price per share that is equal to or greater than the price per share paid by the investor in this offering, and investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which
we sell additional shares of our Common Stock or securities convertible into Common Stock in future transactions may be higher or lower
than the price per share in this offering. You will incur dilution upon exercise of any outstanding stock options, warrants or upon the
issuance of shares of Common Stock under our stock incentive programs. In addition, the sale of shares in this offering and any future
sales of a substantial number of shares of our Common Stock in the public market, or the perception that such sales may occur, could
adversely affect the price of our Common Stock. We cannot predict the effect, if any, that market sales of those shares of Common Stock
or the availability of those shares for sale will have on the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We do not intend to pay dividends on shares
of our Common Stock for the foreseeable future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have never declared or paid any cash dividends
on shares of our Common Stock and do not intend to pay any cash dividends in the foreseeable future. We anticipate that we will retain
all of our future earnings for use in the development of our business and for general corporate purposes. Any determination to pay dividends
in the future will be at the discretion of the Board. Accordingly, investors must rely on sales of their Common Stock after price appreciation,
which may never occur, as the only way to realize any future gains on their investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The shares offered hereby will be sold,
and investors who buy such shares pay, different prices.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investors who purchase shares in this offering
agree to pay different prices, and so may experience different outcomes in their investment results. Investors may experience a decline
in the value of their shares as a result of sales made at prices lower than the prices they paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_006"></A><B>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate that the net proceeds from this offering
will be approximately $2,450,000, after deducting estimated offering expenses payable by us. We intend to use such cash to (i)&nbsp;make
required payment under the EOS Note, (ii)&nbsp;make required payment under the CSI Notes (as defined below) and (iii)&nbsp;accelerate
the Company&rsquo;s supercomputing infrastructure, expand independent data exchanges, unlocking new revenue streams and for working capital
and other general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to an asset purchase agreement between
the Company and EOS, on December&nbsp;31, 2024, we issued to EOS a promissory note in the principal amount of $10,000,000 (the &ldquo;EOS
Note&rdquo;). The EOS Note is due on the third anniversary of the issuance date, accrues interest at the rate of 5.12% per annum and
is convertible into shares of Common Stock. If we enter into any Subsequent Financing, we are required to pay to the holder of the EOS
Note at least 10% of the gross proceeds of such Subsequent Financing to redeem all or a portion of the EOS Note, plus accrued but unpaid
interest, plus liquidated damages, if any, and any other amounts then owing to EOS. If the aggregate gross proceeds of Subsequent Financings
reaches or exceeds $50,000,000, then we must repay the EOS Note in full, including accrued but unpaid interest, liquidated damages, if
any, and any other amounts, then owed to EOS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May&nbsp;20, 2025, we issued convertible notes
(the &ldquo;CSI Notes&rdquo;) to CompuSystems,&nbsp;Inc., a Texas corporation (&ldquo;CSI&rdquo;), each with an original principal amount
of $5,000,000 and $15,000,000 in the aggregate, in connection with the closing (the &ldquo;CSI Closing&rdquo;) of certain asset purchase
by us from CSI. Pursuant to one of the CSI Notes (the &ldquo;Initial CSI Note&rdquo;), in the event the Company raises at least $15,000,000
of capital, the Company is required to notify the holder and pay the note in full. Pursuant to the other two CSI Notes (the &ldquo;First
CSI Note&rdquo; and the &ldquo;Second CSI Note&rdquo;), in the event the Company has cash on hand (inclusive of available revolving lines&#8239;of
credit and/or other similar instruments) of at least $30,000,000 on the business day of any calendar month after the six-month anniversary
of the CSI Closing (with respect to the First CSI Note) and the nine-month anniversary of the CSI Closing (with respect to the Second
CSI Note), the Company is required to notify the holder of the applicable CSI Note that the holder may demand the note be paid in full,
and make such payment upon demand by the holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this prospectus supplement,
we cannot predict with certainty all the uses for the net proceeds to be received upon the completion of this offering. We intend to
use the net proceeds from this offering to (i)&nbsp;make required payment under the EOS Note, (ii)&nbsp;make required payments under
CSI Notes and (iii)&nbsp;accelerate the Company&rsquo;s supercomputing infrastructure, expand independent data exchanges, unlocking new
revenue streams and for working capital and other general corporate purposes. We have not allocated specific amounts of net proceeds
for any of these purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_007"></A><B>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you purchase securities in the offering, you
will experience immediate dilution to the extent of the difference between the offering price per share and our pro forma net tangible
book value per share immediately after the offering. Net tangible book value per share is equal to the amount of our total tangible assets,
less total liabilities, divided by the number of outstanding shares of Common Stock. Our historical net tangible book value as of June&nbsp;30,
2025 was $(41,846,000), or $(0.48) per share of Common Stock. Historical net tangible book value per share represents the amount of our
total tangible assets, less total liabilities, divided by the number of shares of Common Stock outstanding as of June&nbsp;30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our pro forma net tangible book value as of June&nbsp;30,
2025 was $1,189,000, or $0.00 per share of Common Stock. Pro forma net tangible book value represents the amount of our total tangible
assets less our total liabilities, after giving effect to (i)&nbsp;grants made to employees, officers and directors pursuant to the 2018
Long-Term Incentive Plan of restricted stock awards of 1,600,000 on or after July&nbsp;1, 2025, (ii)&nbsp;the issuance of 2,500,000 shares
of common stock on July&nbsp;12, 2025 to acquire certain intellectual property assets, (iii)&nbsp;the issuance of 3,000,000 shares of
common stock on July 30, 2025 to acquire certain intellectual property assets, (iv) the issuance of 10,000,000 shares of common stock
on the conversion of $3,200,000 principal of the EOS Convertible Note, (v) the issuance of 125,266,494 shares of Common Stock issued under
the convertible notes issued pursuant to the securities purchase agreement, dated August&nbsp;4, 2025, and the derecognition of $34,289,000
of liabilities, (vi)&nbsp;the issuance of 30,738,449 shares of Common Stock pursuant to the exchanges agreements dated August&nbsp;4,
2025, (vii)&nbsp;the issuance of 15,000,000 shares of Common Stock to Scilex Holding Company pursuant to a securities purchase agreement
dated September&nbsp;25, 2025, and (viii)&nbsp;the issuance of 5,000,000 shares of Common Stock pursuant to an agreement dated July&nbsp;21,
2025 (collectively, the &ldquo;Pro Forma Adjustments&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the sale by us in this offering of (a)&nbsp;1,470,588
shares of Common Stock at an offering price of $0.34 per share and (b)&nbsp;4,255,319 shares of Common Stock at an offering price of $0.47
per share, after deducting estimated offering expenses payable by us, our as adjusted pro forma net tangible book value as of June&nbsp;30,
2025 was approximately $3,689,000, or $0.01 per share of Common Stock. This represents an immediate increase in as adjusted pro forma
net tangible book value to existing stockholders of $0.01 per share of Common Stock and an immediate dilution to purchasers in this offering
of $0.43 per share of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table illustrates this per-share of Common Stock dilution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 86%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Offering price per share of Common Stock<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">0.44</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Pro forma net tangible book value per share as of June&nbsp;30, 2025</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(0.00</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Increase in pro forma net tangible book value per share attributable to this offering</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.01</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">As adjusted pro forma net tangible book value per share as of June&nbsp;30, 2025 after giving effect to this offering</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.01</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Dilution per share to the new investors in this offering</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.43</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Represents the weighted average offering price.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total number of shares of our common stock
reflected in the discussion and table above, on an actual basis, is based on 284,716,319 shares of Common Stock outstanding as of October&nbsp;17,
2025, but excludes the following as of such date: (i)&nbsp;1,150,012 RSUs that have been issued but have not vested, all of which have
been deferred pursuant to agreement by holders of such RSUs, (ii)&nbsp;11,528,822 shares of Common Stock issuable pursuant to convertible
notes issued on May&nbsp;20, 2025, to CompuSystems,&nbsp;Inc., (iii)&nbsp;4,675,857 shares of Common Stock issuable pursuant to the EOS
Note, all of which has been deferred pursuant to an agreement by the holder of the EOS Note, and (iv)&nbsp;2,750,000 shares of Common
Stock issuable pursuant to an agreement between the Company and NYIAX, all of which has been deferred as agreed by NYIAX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that new options or other securities
are issued under our equity incentive plans, or we issue additional shares of Common Stock or preferred stock in the future, there will
be further dilution to the persons being issued shares of Common Stock in this offering. In addition, we may choose to raise additional
capital because of market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or
future operating plans. If we raise additional capital through the sale of equity or convertible debt securities, the issuance of such
securities could result in further dilution to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_008"></A><B>DESCRIPTION OF SECURITIES THAT WE ARE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The material terms and provisions of our Common Stock are described
under the caption &ldquo;Description of Capital Stock&rdquo; beginning on page&nbsp;21 of the accompanying prospectus. As of the date
of this prospectus supplement, our authorized capital consists of 320,000,000 shares, consisting of (a)&nbsp;300,000,000 shares of Common
Stock, par value $0.0001 per share, and (b)&nbsp;up to 20,000,000 shares of blank check preferred stock, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_009"></A><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of this offering were subject to market
conditions and negotiations between us and the Purchasers. We entered into the Purchase Agreement directly with the Purchasers, who have
agreed to purchase the Shares. The form of the Purchase Agreement is included as an exhibit to a Current Report on Form&nbsp;8-K that
we filed or will file with the SEC and that is incorporated by reference into the registration statement of which this prospectus supplement
forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently anticipate that the Initial Closing will take place on
or about October&nbsp;29, 2025, subject to satisfaction of certain conditions. We estimate that the net proceeds from the offering will
be approximately $2,450,000, after deducting estimated offering expenses payable by us. Our obligation to issue the Additional Shares
is subject to the terms and conditions set forth in the Purchase Agreement, including the receipt of Stockholder Approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transfer agent and registrar for our Common Stock is VStock Transfer,
LLC. Its address is 18 Lafayette Place, Woodmere, NY 11598 and its telephone number is (212) 828-8436.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Common Stock is traded on Nasdaq under the symbol &ldquo;DVLT&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_010"></A><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The validity of the securities being offered
by this prospectus supplement will be passed upon for us by Sullivan&nbsp;&amp; Worcester LLP, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_011"></A><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of Datavault
AI&nbsp;Inc. as of December&nbsp;31, 2023 and 2022 and for each of the two years in the period ended December&nbsp;31, 2024, incorporated
in this prospectus supplement by reference to the <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm">Annual
Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024,</A> have been so incorporated in reliance on the report (which contains
an explanatory paragraph relating to the Company&rsquo;s ability to continue as a going concern as described in Note 2 to the consolidated
financial statements) of BPM LLP, an independent registered public accounting firm, given on the authority of said firm as experts in
auditing and accounting. The consolidated financial statements of CompuSystems,&nbsp;Inc. for the fiscal years ended December&nbsp;31,
2024 and 2023 incorporated in this prospectus by reference to the&nbsp;<A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925061666/tm2518588d1_8ka.htm">Current
Report on Form&nbsp;8-K filed with the SEC on June&nbsp;23, 2025</A>, &nbsp;have been so incorporated in reliance on the report of BG
Advisors CPA,&nbsp;Ltd., an independent registered public accounting firm, given on the authority of said firm as experts in auditing
and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_012"></A><B>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have filed with the SEC a registration statement
on Form&nbsp;S-3 under the Securities Act with respect to the securities offered by this prospectus supplement. This prospectus supplement
and the accompanying prospectus, which are part of the registration statement, omits certain information, exhibits, schedules and undertakings
set forth in the registration statement, as permitted by the SEC. For further information pertaining to us and the securities offered
in this prospectus supplement, reference is made to that registration statement and the exhibits and schedules to the registration statement.
Statements contained in this prospectus supplement and the accompanying prospectus as to the contents or provisions of any documents
referred to in this prospectus are not necessarily complete, and in each instance where a copy of the document has been filed as an exhibit
to the registration statement, reference is made to the exhibit for a more complete description of the matters involved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We file annual, quarterly and current reports,
proxy statements and other information with the SEC. You can read our electronic SEC filings, including such registration statement,
on the internet at the SEC&rsquo;s website at <I>www.sec.gov</I>. We are subject to the information reporting requirements of the Exchange
Act, and we file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information
will be available at the website of the SEC referred to above. We also maintain a website at <I>www.datavaultsite.com</I>, at which you
may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to,
the SEC. However, the information contained in or accessible through our website is not part of this prospectus supplement, the accompanying
prospectus or any other prospectus supplement that we file, and investors should not rely on such information in making a decision to
purchase our securities in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_013"></A><B>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incorporate by reference the filed documents
listed below (excluding those portions of any Current Report on Form&nbsp;8-K that are not deemed &ldquo;filed&rdquo; pursuant to the
General Instructions of Form&nbsp;8-K), except as superseded, supplemented or modified by this prospectus supplement or any subsequently
filed document incorporated by reference herein as described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm">our
    Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on March&nbsp;31, 2025;</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825001273/dvlt-20250331x10q.htm">our
    Quarterly Reports on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2025, filed with the SEC on May&nbsp;14, 2025 and for the
    quarter ended June&nbsp;30, 2025, filed with the SEC on August&nbsp;19, 2025;</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Reports on
    Form&nbsp;8-K filed with the SEC on&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925001395/tm252064d2_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January&nbsp;6,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925001736/tm252064d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January&nbsp;7,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925002022/tm252259d1_8ka.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January&nbsp;8,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925012422/tm256455d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February&nbsp;13,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(the first Current Report on Form&nbsp;8-K
    filed on such date),&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925012760/tm256455d2_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February&nbsp;13,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(the second Current Report on Form&nbsp;8-K
    filed on such date),&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925014230/tm256656d2_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February&nbsp;14,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925019129/tm257883d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February&nbsp;28,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925024238/tm259436d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&nbsp;17,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925024238/tm259436d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&nbsp;31,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(the first Current Report on Form&nbsp;8-K
    filed on such date),&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925029947/tm2510880d2_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&nbsp;31,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(the second Current Report on Form&nbsp;8-K
    filed on such date),&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925031132/tm2511063d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April&nbsp;2,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925032260/tm2511578d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April&nbsp;4,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925034671/tm2512185d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April&nbsp;14,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925046741/tm2514424d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;9,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925046773/tm2514540d1_8ka.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;9,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925049498/tm2515254d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;15,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925050650/tm2515584d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;20,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925050650/tm2515584d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;20,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,&nbsp;</FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925061666/tm2518588d1_8ka.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;23,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925067407/tm2520617d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July&nbsp;11,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925068671/tm2520909d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July&nbsp;17,
    2025</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the first Current Report on Form&nbsp;8-K
    filed on such date), </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925068679/tm2520861d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July&nbsp;17,
    2025</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the second Current Report on Form&nbsp;8-K
    filed on such date), </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925069446/tm2521239d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July&nbsp;22,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925072283/tm2521921d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July&nbsp;31,
    2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925073703/tm2522493d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August&nbsp;4,
    2025</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(except for Item 2.02 and Item 7.01 of any
    Current Report on Form&nbsp;8-K which are not deemed &ldquo;filed&rdquo; for purposes of Section&nbsp;18 of the Exchange Act and
    are not incorporated by reference in this prospectus), <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925075739/tm2522984d1_8k.htm" STYLE="-sec-extract: exhibit">August&nbsp;8, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925076862/tm2523192d1_8k.htm" STYLE="-sec-extract: exhibit">August&nbsp;12, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925080564/tm2523964d1_8k.htm" STYLE="-sec-extract: exhibit">August&nbsp;20, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925081876/tm2524125d1_8k.htm" STYLE="-sec-extract: exhibit">August&nbsp;22, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925085677/tm2524780d1_8k.htm" STYLE="-sec-extract: exhibit">August&nbsp;29, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925088049/tm2525483d1_8k.htm" STYLE="-sec-extract: exhibit">September&nbsp;8, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925093831/tm2526979d2_8k.htm" STYLE="-sec-extract: exhibit">September&nbsp;26, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925093893/tm2526979d1_8k.htm" STYLE="-sec-extract: exhibit">September&nbsp;26, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925094127/tm2527341d1_8k.htm" STYLE="-sec-extract: exhibit">September&nbsp;29, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925095668/tm2527645d1_8k.htm" STYLE="-sec-extract: exhibit">October&nbsp;1, 2025</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925099017/tm2528655d1_8k.htm" STYLE="-sec-extract: exhibit">October&nbsp;14, 2025</A>; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our
    common stock contained in (i)&nbsp;our registration statement on&nbsp;Form&nbsp;8-A, filed with the SEC on </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1682149/000114420418039919/tv499143_8-a12b.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July&nbsp;25,
    2018</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;under Section&nbsp;12(b)&nbsp;of the
    Exchange Act, including any amendments or reports filed for the purpose of updating such description and (ii)&nbsp;</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231xex4d2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit&nbsp;4.2</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;Description
    of Securities Registered Pursuant to Section&nbsp;12 of the Securities Exchange Act of 1934, to <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm" STYLE="-sec-extract: exhibit">our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on March&nbsp;31, 2025</A>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also incorporate by reference in this prospectus
supplement and the accompanying prospectus any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d)&nbsp;of the
Exchange Act after the date hereof but before the completion or termination of this offering (excluding any information not deemed &ldquo;filed&rdquo;
with the SEC).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statement contained in a document incorporated
by reference herein or therein shall be deemed to be modified or superseded for all purposes to the extent that a statement contained
in this prospectus supplement and the accompanying base prospectus or in any other subsequently filed document which is also incorporated
or deemed to be incorporated by reference herein or therein, modifies or supersedes such statement. Any statement so modified or superseded
shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement and the accompanying base
prospectus. You may request a copy of these filings (other than an exhibit to a filing unless that exhibit is specifically incorporated
by reference into that filing) at no cost by writing, telephoning or e-mailing us at the following address, telephone number or e-mail
address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Datavault AI&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">15268 NW Greenbrier Pkwy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Beaverton, OR 97006</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(408) 627-4716</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>info@wisatechnologies.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Copies of these filings are also available through the &ldquo;Investor
Relations&rdquo; section of our website at <I>www.datavaultsite.com.</I> For other ways to obtain a copy of these filings, please refer
to &ldquo;Where You Can Find More Information&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$250,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2529329d1_424b5img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Datavault AI Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock<BR>
Preferred Stock<BR>
Debt Securities<BR>
Warrants<BR>
Rights<BR>
Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Datavault AI Inc. (the &ldquo;Company&rdquo;,
 &ldquo;we&rdquo;, &ldquo;us&rdquo; or &ldquo;our&rdquo;) may offer and sell, from time to time in one or more offerings in traditional
certificated form or in uncertificated form, any combination of common stock, preferred stock, debt securities, warrants, rights, or
units having an aggregate offering price not exceeding $250,000,000. The preferred stock, debt securities, warrants, rights, and units
may be exercisable or exchangeable for common stock or preferred stock or other securities of ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus provides a general description
of the securities that we may offer. We will provide specific terms of the offerings of our securities in one or more supplements to
this prospectus. The prospectus supplement may also add, update or change information in this prospectus. You should read this prospectus
and any prospectus supplement, as well as the documents incorporated by reference or deemed to be incorporated by reference into this
prospectus, carefully before you invest in any of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This prospectus may not be used to offer or
sell our securities unless accompanied by a prospectus supplement relating to the offered securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These securities may be sold directly by us,
through dealers or agents designated from time to time, to or through underwriters, dealers or through a combination of these methods
on a continuous or delayed basis. For additional information on the methods of sale, see the section entitled &ldquo;Plan of Distribution&rdquo;
in this prospectus. We will also describe the plan of distribution for any particular offering of our securities in a prospectus supplement.
If any agents, underwriters or dealers are involved in the sale of any securities in respect of which this prospectus is being delivered,
we will disclose their names and the nature of our arrangements with them in a prospectus supplement. The price to the public of such
securities and the net proceeds we expect to receive from any such sale will also be included in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is currently listed on the Nasdaq
Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;DVLT&rdquo;. On July&nbsp;3, 2025, the last reported sale price of our
common stock on Nasdaq was $0.72.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate market value of our outstanding
common stock held by non-affiliates is $51,070,730, based on 84,662,309 shares of outstanding common stock on July&nbsp;2, 2025, of which
70,931,570 are held by non-affiliates, and a per share price of $0.72, based on the closing sale price of our common stock on July&nbsp;3,
2025. Pursuant to General Instruction I.B.6 of Form&nbsp;S-3, in no event will we sell our common stock in a public primary offering
with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75,000,000.
During the previous 12 calendar months prior to and including the date of this prospectus, we had not offered any of our securities pursuant
to General Instruction I.B.6 of Form&nbsp;S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves risks.
You should carefully review the risks described under the heading &ldquo;Risk Factors&rdquo; beginning on page&nbsp;4</B>&nbsp;<B>and
in the documents which are incorporated by reference herein and contained in the applicable prospectus supplement before you invest in
our securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 95%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL NOTE REGARDING FORWARD-LOOKING
    STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE SECURITIES WE MAY&nbsp;OFFER</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF RIGHTS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="text-align: center"><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should rely only on the information contained
in this prospectus and any accompanying prospectus supplement or incorporated by reference in these documents. No dealer, salesperson
or other person is authorized to give any information or to represent anything not contained or incorporated by reference in this prospectus
or the accompanying prospectus supplement. If anyone provides you with different, inconsistent or unauthorized information or representations,
you must not rely on them. This prospectus and any accompanying prospectus supplement are an offer to sell only the securities offered
by these documents, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this
prospectus or any prospectus supplement is current only as of the date on the front of those documents.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_001"></A><FONT STYLE="text-transform: uppercase"><B>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus is part of a registration statement
that we filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) using a &ldquo;shelf&rdquo; registration process.
Under this shelf registration process, we may sell any combination of the securities described in this prospectus in one or more offerings
from time to time having an aggregate offering price of up to $250,000,000. This prospectus provides you with a general description of
the securities that we may offer. Each time that we offer securities, we will provide you with a prospectus supplement that describes
the specific amounts, prices and terms of the securities that we offer. The prospectus supplement also may add, update or change information
contained in this prospectus. You should read carefully both this prospectus, including the section entitled &ldquo;Risk Factors,&rdquo;
and any prospectus supplement, together with the additional information described below under the headings &ldquo;Where You Can Find
More Information&rdquo; and &ldquo;Incorporation of Documents by Reference&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, this prospectus does not contain
all the information provided in the registration statement that we filed with the SEC. For further information, we refer you to the registration
statement, including its exhibits. The registration statement can be read on the SEC&rsquo;s website or at the SEC&rsquo;s offices mentioned
below under the heading &ldquo;Where You Can Find More Information&rdquo;. Statements contained in this prospectus and any prospectus
supplement about the provisions or contents of any agreement or other document are not necessarily complete. If the SEC&rsquo;s rules&nbsp;and
regulations require that an agreement or document be filed as an exhibit to the registration statement, please see that agreement or
document for a complete description of such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should rely only on the information contained
or incorporated by reference in this prospectus and any prospectus supplement. We have not authorized any other person to provide you
with different information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus
is not an offer to sell securities, and it is not soliciting an offer to buy securities in any jurisdiction where the offer or sale is
not permitted. You should assume that the information appearing in this prospectus or any prospectus supplement, as well as information
we have previously filed with the SEC and incorporated by reference, is accurate as of the date on the front of those documents only.
Our business, financial condition, results of operations and prospects may have changed since those dates. This prospectus may not be
used to consummate a sale of our securities unless it is accompanied by a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this prospectus, we refer to Datavault AI
Inc. as &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo; &ldquo;DVLT,&rdquo; and the &ldquo;Company&rdquo;, unless we specifically
state otherwise or the context indicates otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_002"></A><FONT STYLE="text-transform: uppercase"><B>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus, the applicable prospectus supplement
and the information incorporated by reference in this prospectus contain various forward-looking statements within the meaning of Section&nbsp;27A
of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) and Section&nbsp;21E of the Securities and Exchange Act
of 1934, as amended (the &ldquo;Exchange Act&rdquo;), which represent our expectations or beliefs concerning future events. Forward-looking
statements include statements that are predictive in nature, which depend upon or refer to future events or conditions, and/or which
include words such as &ldquo;believes,&rdquo; &ldquo;plans,&rdquo; &ldquo;intends,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;estimates,&rdquo;
 &ldquo;expects,&rdquo; &ldquo;may,&rdquo; &ldquo;will&rdquo; or similar expressions. In addition, any statements concerning future financial
performance, ongoing strategies or prospects, and possible future actions, which may be provided by our management, are also forward-looking
statements. Forward-looking statements are based on current expectations and projections about future events and are subject to risks,
uncertainties, and assumptions about our company, economic and market factors, and the industry in which we do business, among other
things. These statements are not guarantees of future performance, and we undertake no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events, or otherwise, except as required by law. Actual events and results
may differ materially from those expressed or forecasted in forward-looking statements due to a number of factors. Factors that could
cause our actual performance, future results and actions to differ materially from any forward-looking statements include, but are not
limited to, those discussed under the heading &ldquo;Risk Factors&rdquo; in this prospectus and in any of our filings with the SEC pursuant
to Sections 13(a), 13(c), 14 or 15(d)&nbsp;of the Exchange Act. The forward-looking statements in this prospectus, any applicable prospectus
supplement and the information incorporated by reference herein or therein represent our views as of the date such statements are made.
These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date such statements
are made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_003"></A><FONT STYLE="text-transform: uppercase"><B>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a pioneering technology licensing company
that owns a portfolio of patented, secure platforms designed to redefine how data is managed, valued, and monetized in the modern era.
Leveraging our proprietary HPC capabilities and advanced software, we aim to empower customers worldwide with revolutionary data solutions.
At the heart of our offerings are our artificial intelligence (AI)-driven agents&mdash;branded as Data Vault&reg;, DataValue&reg;, DataScore&reg;,
and Data Vault Bank&reg;. These tools harness generative AI to deliver enterprise-grade data management solutions tailored for the HPC
landscape and the Web 3.0 paradigm. Our technology ensures data ownership immutability, experiential data observability, precise data
asset valuation, and secure monetization&mdash;which we believe will unlock unprecedented opportunities for businesses in an increasingly
data-driven world on which our executive leadership, with our engineering and software development teams, can capitalize. Our legacy
business has been well positioned to deliver best-in-class immersive wireless sound technology for intelligent devices and next generation
home entertainment systems, including modules which wirelessly transmit and receive audio directly to speakers. We operate through two
synergistic platforms (Data Science and Acoustic Science) to optimize our revenue generation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risk Factor Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are a number of risks related to our business
and our securities. You should carefully consider all the information presented in the section entitled &ldquo;Risk Factors&rdquo; in
this prospectus. Some of the principal risks related to our business include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our incurrence of losses since inception;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks related to future acquisitions and our ability
    to manage our business and our results of operations and financial condition;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks related to outages, defects and other performance
    and quality problems in connection with acquired assets and businesses;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fact that a small number of customers represent
    a significant percentage of our revenue;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our reliance on module manufacturers to produce the
    modules which we then sell to our customers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks incident to operating internationally;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to protect our intellectual property rights;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our dependence upon the timely delivery of products
    from our vendors and purchases from our partners and customers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">real or perceived errors, failures or bugs in our modules;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the seasonal nature of our operations;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic downturns and the potential for declines
    in discretionary consumer spending;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain the listing of our common stock
    on the Nasdaq Capital Market; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other risks set forth in &ldquo;Risk Factors&rdquo;
    below.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our principal executive office is located at
15268 NW Greenbrier Pkwy, Beaverton, Oregon 97006 and our telephone number is (408) 627-4716. Our website address is&nbsp;<I>www.datavaultsite.com</I>.
The website for our associated brands, manufacturers and influencers within the consumer electronics industry is&nbsp;<I>http://www.wisaassociation.org</I>.
The information contained on, or that can be accessed through, our websites is not incorporated by reference into this prospectus and
is intended for informational purposes only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional information about us is included in
documents incorporated by reference in this prospectus. See &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Information
Incorporated by Reference.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_004"></A><FONT STYLE="text-transform: uppercase"><B>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Investing in our securities involves significant
risk. The prospectus supplement applicable to each offering of our securities will contain a discussion of the risks applicable to an
investment in our securities. Prior to investing in our securities, you should carefully consider the specific factors discussed under
the heading &ldquo;Risk Factors&rdquo; in this prospectus and any applicable prospectus supplement, together with all of the other information
contained or incorporated by reference herein or therein. The risks and uncertainties we have described are not the only ones we face.
Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. The
occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to Our Financial Condition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our revenue and loss from operations forecasts
are subject to change as a result of a variety of risks and uncertainties.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenue and loss from operations forecasts
can change as a result of a variety of factors including but are not limited to changes in sales levels, unexpected increases in product
costs and increases in operating costs. Significant changes from our current forecasts, including but not limited to: (i)&nbsp;shortfalls
from projected sales levels; (ii)&nbsp;unexpected increases in product costs; (iii)&nbsp;increases in operating costs; and (iv)&nbsp;inability
to regain and maintain compliance with the Nasdaq continued listing requirements, could have a material adverse impact on our ability
to access the level of funding necessary to continue our operations at current levels. If any of these events occurs or if we are not
able to secure additional funding, we may be forced to make reductions in spending, liquidate assets where possible, and/or suspend or
curtail planned programs. Any of these actions could materially harm our business, revenues, results of operations and future prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We need financing in the near term to support
our ongoing operations. If we do not raise sufficient capital in the short term, we may be forced to cease operations, liquidate our
assets and possibly seek bankruptcy protection or engage in a similar process.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We are currently operating
at a loss and our cash position is insufficient to fund operations in the near term. As such,&nbsp;we need additional financing to implement
our business plan and to service our ongoing operations.&nbsp;We believe that current cash on hand is not sufficient to fund our immediate
operational needs.&nbsp;There can be no assurance that we will be able to secure any needed funding, or that if such funding is available,
the terms or conditions would be acceptable to us. If we are unable to obtain additional financing in the short term, we will be required
to divest all or a portion of our business or otherwise liquidate, wind-up, restructure or curtail our operations and product development
timeline.&nbsp;We may seek additional capital through a combination of equity offerings, such as this offering, debt financings and/or
strategic collaborations. If such financing is not available on satisfactory terms, or is not available at all, our ability to accelerate
product development will be hindered, our business and financial condition may be materially and adversely affected, and you may lose
all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We have incurred losses since inception.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have incurred net losses since inception and
had an accumulated deficit of approximately $308.0 million as of March 31, 2025. If we are unsuccessful in implementing any initiatives
to improve our revenues to achieve profitability, it will have a material adverse impact on our business, prospects, operating results
and financial condition. There can be no assurance that the revenue that we generate will be able to support our operations or meet our
working capital needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our independent registered public accounting
firm&rsquo;s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a going concern.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our independent registered public accounting
firm has included in its report for the year ended December&nbsp;31, 2024 an explanatory paragraph expressing substantial doubt about
our ability to continue as a going concern. Our consolidated financial statements have been prepared on a going concern basis, which
contemplates the realization of assets and the discharge of liabilities in the normal course of business. Our ability to continue as
a going concern is contingent upon, other factors, our ability to raise additional capital through sales of our securities, including
this offering, and incurrence of debt. Additionally, future capital requirements will depend on many factors, including the rate of revenue
growth, the selling price of our products, the expansion of sales and marketing activities, the timing and extent of spending on research
and development efforts and the continuing market acceptance of our products. These factors raise substantial doubt about our ability
to continue as a going concern. There is no assurance that additional financing will be available at terms acceptable to us or at all.
If we cannot continue as a viable entity, this could materially adversely affect the value of the shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Business and Industry</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Legacy Datavault (as defined below) has
a limited operating history, which makes it difficult to forecast our future results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of Legacy Datavault&rsquo;s limited
operating history, our ability to accurately forecast future results from the operations of the Legacy Datavault business is limited
and subject to a number of uncertainties, including our ability to plan for and model future growth. Further, in future periods, our
revenue growth from the Legacy Datavault business could slow or its revenue could decline for a number of reasons, including slowing
demand for its platform, increased competition, changes to technology, a decrease in the growth of its overall market, or its failure,
for any reason, to continue to take advantage of growth opportunities. We have also encountered, and will continue to encounter, risks
and uncertainties frequently experienced by growing companies in rapidly changing industries, such as the risks and uncertainties described
below. If our assumptions regarding these risks and uncertainties and its future revenue growth are incorrect or change, or if we do
not address these risks successfully, our operating and financial results could differ materially from our expectations, and our business
could suffer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may not have visibility into our financial
position and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the future, customers will consume our platform
through license and the use of our software as a service platform for the data refinery, meta data layer creation, and through the monetization
of data assets. Because prospective customers have flexibility in the timing of their consumption, we may not have the visibility into
the timing of revenue recognition that a typical subscription-based software company has. There is a risk that customers will consume
our platform more slowly than we expect, and our actual results may differ from our forecasts. Further, investors and securities analysts
may not understand how our consumption-based business model differs from a subscription-based business model, and our business model
may be compared to subscription-based business models.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sales efforts to large customers involve
risks that may not be present or that are present to a lesser extent with respect to sales to smaller organizations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales to large customers involve risks that may
not be present or that are present to a lesser extent with sales to smaller organizations, such as longer sales cycles, more complex
customer requirements, substantial upfront sales costs, and less predictability in completing some of Data Vault&rsquo;s sales. For example,
large customers may require considerable time to evaluate and test Data Vault&rsquo;s platform prior to making a purchase decision and
placing an order. A number of factors influence the length and variability of Data Vault&rsquo;s sales cycle, including the need to educate
potential customers about the uses and benefits of Data Vault&rsquo;s platform, the discretionary nature of purchasing and budget cycles,
and the competitive nature of evaluation and purchasing approval processes. As a result, the length of Data Vault&rsquo;s sales cycle,
from identification of the opportunity to deal closure, may vary significantly from customer to customer, with sales to large enterprises
typically taking longer to complete. Moreover, large customers often begin to deploy Data Vault&rsquo;s products on a limited basis but
nevertheless demand implementation services and negotiate pricing discounts, which increase Data Vault&rsquo;s upfront investment in
the sales effort with no guarantee that sales to these customers will justify Data Vault&rsquo;s substantial upfront investment. If we
fail to effectively manage these risks associated with sales cycles and sales to large customers, Data Vault&rsquo;s business, financial
condition, and results of operations may be affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>A small number of customers represent a
significant percentage of our revenue, so any loss of key customers could have a material adverse effect on our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">A small number of our
customers represent a significant percentage of our revenue. Although we may have agreements with these customers, these agreements typically
do not require any minimum purchases and do not prohibit customers from using competing technologies or customers from purchasing products
and services from competitors. Because many of our markets are rapidly evolving, customer demand for our technologies and products can
shift quickly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of December&nbsp;31,
2024, the Company had&nbsp;three&nbsp;customers accounting for&nbsp;68%, 12%, and 11% of accounts receivable. As of December&nbsp;31,
2023, the Company had&nbsp;two&nbsp;customers accounting for&nbsp;71% and&nbsp;20% of accounts receivable. The Company had&nbsp;four&nbsp;customers
accounting for&nbsp;29%, 19%, 18% and 10% of its net revenue for the year ended December&nbsp;31, 2024. The Company had&nbsp;four&nbsp;customers
accounting for&nbsp;25%,&nbsp;19%,&nbsp;14% and&nbsp;13% of its net revenue for the year ended December&nbsp;31, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A loss of any of our key customers could have
a material adverse effect on our business and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We are reliant on module manufacturers
to produce the modules which we then sell to our customers and any change in their management or business could have a negative effect
on our operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenue from the sale of modules to consumer
electronics and speaker companies depends in large part upon the availability of our modules that implement our technologies. Our manufacturers
incorporate our technologies into these modules, which are then incorporated in consumer entertainment products. We do not manufacture
these modules, but rather depend on manufacturers to produce the modules which we then sell to our customers. We do not control the manufacturers.
While we have a longstanding relationship with our manufacturers, there can be no assurance that our manufacturers will continue to timely
produce our modules. Change in management of our manufacturers or a change in their operations could negatively affect our production
and cause us to seek other manufacturers which we may not be able to obtain on the same or similar terms as our current manufacturers.
This could have a negative effect on our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We currently rely on semiconductor manufacturers
to manufacture our semiconductors, and our failure to manage our relationship with our semiconductor manufacturers successfully could
negatively impact our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We rely on a single contractor in Japan for the
production of our transmit semiconductor chip and a single contractor in China for the production of our receive semiconductor chip.
Our reliance on these semiconductor manufacturers reduces our control over the manufacturing process, exposing us to risks, including
increase production costs and reduced product supply. If we fail to manage our relationships with these manufacturers effectively, or
if a contract manufacturer experiences delays, disruptions, or decides to end-of-life components that it manufactures for us, our ability
to ship products to our end-user customers could be impaired and our competitive position and reputation could be harmed. In addition,
any adverse change in our manufacturers&rsquo; financial or business condition could disrupt our ability to supply quality products to
our end-user customers. If we are required to change manufacturers, we may lose revenue, incur increased costs and damage our customer
relationships. In addition, qualifying a new semiconductor manufacturer and commencing production can be an expensive and lengthy process.
As a result of any of these aforementioned disruptions, we would experience a delay in our order fulfillment, and our business, operating
results and financial condition would be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Declines in or problems with the WiSA Association
membership could negatively affect our reputation.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our wholly owned subsidiary, WiSA, LLC, operates
the &ldquo;WiSA Association,&rdquo; which is an association comprised of brands, manufacturers, and influencers within the consumer electronics
industry, with the purpose of promoting a standardized method of interoperability between wireless audio components using our technology.
We rely significantly on the WiSA Association to uphold the standards and criteria of interoperable audio products. If we lose members
or new technology is developed that is easier to incorporate than ours, the WiSA Association may fail to maintain its active status and
the sales of our modules could diminish as well. In addition, failure of our members to adhere to our policies designed to provide interoperability
between audio systems could undermine the integrity of our brand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Failure to stay on top of technology innovation
could harm our business model.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenue growth will depend upon our success
in new and existing markets for our technologies. The markets for our technologies and products are defined by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rapid technological change;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">new and improved technology
    and frequent product introductions;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consumer demands; evolving
    industry standards; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">technology and product
    obsolescence.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our future success depends on our ability to
enhance our technologies and products and to develop new technologies and products that address the market needs in a timely manner.
Technology development is a complex, uncertain process requiring high levels of innovation, highly skilled engineering and development
personnel, and the accurate anticipation of technological and market trends. We may not be able to identify, develop, acquire, market,
or support new or enhanced technologies or products on a timely basis, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Failure to effectively develop and expand
our sales and marketing capabilities could harm our ability to increase our customer base and achieve broader market acceptance of our
modules.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To increase total customers and customer recognition
of the WiSA Association products and to achieve broader market acceptance of our technology, we will need to expand our sales and marketing
organization and increase our business development resources, including the vertical and geographic distribution of our sales force and
our teams of account executives focused on new accounts and responsible for renewal and growth of existing accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business requires that our sales personnel
have particular expertise and experience in interoperability of audio systems, and the latest wireless audio technology. We may not achieve
revenue growth from expanding our sales force if we are unable to hire, develop and retain talented sales personnel with appropriate
experience, if our new sales personnel are unable to achieve desired productivity levels in a reasonable period of time or if our sales
and marketing programs are not effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Interruptions or performance problems associated
with technology and wireless technology outside of our control may adversely affect our business and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may in the future experience performance issues
due to a variety of factors, including wireless technology disruptions, human or software errors. If a wireless connection is compromised,
our products will not work as designed and our business could be negatively affected. In some instances, we may not be able to identify
the cause or causes of these performance problems within an acceptable period or a connection problem may be out of our control and could
deter customers from purchasing wireless audio components.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to continue to make significant investments
to maintain and improve the performance of our modules. To the extent that we do not effectively address capacity constraints, upgrade
our systems as needed and continually develop our technology to accommodate actual and anticipated changes in technology, our business,
operating results and financial condition may be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Real or perceived errors, failures or bugs
in our modules could adversely affect our operating results and growth prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because our modules are complex, undetected errors,
failures or bugs may occur. Our module is installed and used in numerous audio systems of different brands with different operating systems,
system management software, and equipment and networking configurations, which may cause errors or failures of our technology. Despite
our testing, errors, failures or bugs may not be found in our modules until it is released to our customers. Moreover, our customers
could incorrectly implement or inadvertently misuse our modules, which could result in customer dissatisfaction and adversely impact
the perceived quality or utility of our products as well as our brand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any of these real or perceived errors, compatibility
issues, failures or bugs in our modules could result in negative publicity, reputational harm, loss of competitive position or claims
by customers for losses sustained by them. In such an event, we may be required, or may choose, for customer relations or other reasons,
to expend additional resources to correct the problem. Alleviating any of these problems could require significant expenditures of our
capital and other resources and could cause interruptions or delays in the use of our solutions, which could cause us to lose existing
or potential customers and could adversely affect our operating results and growth prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We rely on the cooperation of our customers
to install our modules in their audio products.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our modules are sold to our customers who are
consumer electronics companies. Our customers install the modules into their products. Our customers&rsquo; audio products are sold to
the public who must then install the audio system into their homes or businesses. We do not oversee installation of our products and
therefore have no control over the result. If a module is not installed correctly in a customer product or an end consumer does not install
their audio system correctly, our technology may not work properly, which could result in customer dissatisfaction or have a material
adverse impact on our reputation, our business and our financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we do not or cannot maintain cutting
edge technology and compatibility of our modules with products that our customers use, our business could suffer.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our customers integrate our modules into their
products. The functionality and popularity of our technology depends, in part, on our ability to produce modules that integrate into
our customers&rsquo; products. Our customers may change the features of their technologies and audio systems may advance technologically.
Such changes or advancements could functionally limit or terminate the utility of our product, which could negatively impact our customer
service and harm our business. If we fail to maintain cutting edge technology and compatibility with the products our customers produce,
we may not be able to offer the functionality that our customers need, and our customers may not purchase our modules, which would negatively
impact our ability to generate revenue and have a material adverse impact on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our future quarterly results of operations
may fluctuate significantly due to a wide range of factors, which makes our future results difficult to predict.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenues and results of operations could
vary significantly from quarter to quarter because of various factors, many of which are outside of our control, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the expansion of our customer base;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the recent acquisition of certain assets pursuant to
    the Asset Purchase Agreement (as defined below);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the renewal of agreements with, and expansion of coverage
    by, existing customers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the size, timing and terms of our sales to both existing
    and new customers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the introduction of products
    or services that may compete with us for the limited funds available to our customers, and changes in the cost of such products or
    services;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our customers&rsquo; and potential customers&rsquo;
    budgets;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to control costs, including our operating
    expenses;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to hire, train and maintain our direct
    sales force, engineers, and marketing employees;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the timing of satisfying revenue recognition criteria
    in connection with initial deployment and renewals;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic and political conditions, both domestically
    and internationally; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the effects of outbreaks, epidemics or pandemics of
    contagious diseases.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any one of these or other factors discussed elsewhere
in this prospectus, or the documents incorporated by reference herein, may result in fluctuations in our revenues and operating results,
meaning that quarter-to-quarter comparisons of our revenues, results of operations and cash flows may not necessarily be indicative of
our future performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of the fluctuations described above,
our ability to forecast revenues is limited and we may not be able to accurately predict our future revenues or results of operations.
In addition, we base our current and future expense levels on our operating plans and sales forecasts, and our operating expenses are
expected to be relatively fixed in the short term. Accordingly, we may not be able to reduce our costs sufficiently to compensate for
an unexpected shortfall in revenues, and even a small shortfall in revenues could disproportionately and adversely affect our financial
results for that quarter. The variability and unpredictability of these and other factors could result in our failing to meet or exceed
financial expectations for a given period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our sales are subject to fluctuation as
a result of seasonality, which is outside of our control.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our sales are subject to the seasonality of when
consumers buy electronic products, generally in the third quarter leading up to the year-end holiday season. Our customers&rsquo; plans
to complete and ship new products to meet this seasonal peak can critically impact our financial results should they miss the holiday
season. As a result of these factors, our financial results for any single quarter or for periods of less than a year are not necessarily
indicative of the results that may be achieved for a full fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our sales are subject to fluctuation as
a result of our customers&rsquo; new product introduction timelines and end-user adoption of our customers&rsquo; retail products, both
of which are outside of our control.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We, in conjunction with our customers, are launching
a new technology to the retail and consumer market. The consumer adoption rate at retail is a critical component of our financial success
and is currently an unknown component of our financial plans. The variability and unpredictability of these and other factors could result
in our failing to meet or exceed financial expectations for a given period. As a result of these factors, our financial results for any
single quarter or for periods of less than a year are not necessarily indicative of the results that may be achieved for a full fiscal
year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We conduct international operations, which
exposes us to significant risks.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our headquarters are located in Oregon, but we
also have employees in Taiwan and Korea and representatives in China and Japan. Operating in international markets requires significant
resources and management attention and subjects us to regulatory, economic and political risks in addition to those we already face in
the United States. In addition, we invest time and resources in understanding the regulatory framework and political environments of
our customers overseas in order to focus our sales efforts. Because such regulatory and political considerations are likely to vary across
jurisdictions, this effort requires additional time and attention from our sales team and could lead to a sales cycle that is longer
than our typical process for sales in the United States. We also may need to hire additional employees and otherwise invest in our international
operations in order to reach new customers. Because of our limited experience with international operations as well as developing and
managing sales in international markets, our international efforts may not be successful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we will face risks in doing business
internationally that could adversely affect our business, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the potential impact of
    currency exchange fluctuations;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the difficulty of staffing
    and managing international operations and the increased operations, travel, shipping and compliance costs associated with having
    customers in numerous international locations;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially greater difficulty collecting accounts
    receivable and longer payment cycles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the need to offer customer support in various languages;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges in understanding and complying with local
    laws, regulations and customs in foreign jurisdictions;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">export controls and economic
    sanctions administered by the Department of Commerce Bureau of Industry and Security and the Treasury Department&rsquo;s Office of
    Foreign Assets Control;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance with various anti-bribery and anti-corruption
    laws such as the Foreign Corrupt Practices Act and United Kingdom Bribery Act of 2010;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tariffs and other non-tariff barriers, such as quotas
    and local content rules;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">more limited protection for our intellectual property
    in some countries;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse or uncertain tax consequences as a result of
    international operations;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency control regulations, which might restrict
    or prohibit our conversion of other currencies into U.S. dollars;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions on the transfer of funds;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deterioration of political relations between the United
    States and other countries; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">political or social unrest
    or economic instability in a specific country or region in which we operate, which could have an adverse impact on our operations
    in that location.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, we expect that due to costs related to
our international efforts and the increased cost of doing business internationally, we will incur higher costs to secure sales to international
customers than the comparable costs for domestic customers. As a result, our financial results may fluctuate as we expand our operations
and customer base worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our failure to manage any of these risks successfully
could harm our international operations and adversely affect our business, operating results and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We are dependent on the continued services
and performance of our senior management and other key personnel, the loss of any of whom could adversely affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our future success depends in large part on the
continued contributions of our senior management and other key personnel. In particular, the leadership of key management personnel is
critical to the successful management of our Company, the development of our products, and our strategic direction. We also depend on
the contributions of key technical personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not maintain &ldquo;key person&rdquo; insurance
for any member of our senior management team or any of our other key employees. Our senior management and key personnel are all employed
on an at-will basis, which means that they could terminate their employment with us at any time, for any reason and without notice. The
loss of any of our key management personnel could significantly delay or prevent the achievement of our development and strategic objectives
and adversely affect our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cyber-security incidents, including data
security breaches or computer viruses, could harm our business by disrupting our delivery of products or services, damaging our reputation
or exposing us to liability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We receive, process, store and transmit, often
electronically, the data of our customers and others, much of which is confidential. Unauthorized access to our computer systems or stored
data could result in the theft, including cyber-theft, or improper disclosure of confidential information, and the deletion or modification
of records could cause interruptions in our operations. These cyber-security risks increase when we transmit information from one location
to another, including over the Internet or other electronic networks. Despite the security measures we have implemented, our facilities,
systems and procedures, and those of our third-party service providers, may be vulnerable to security breaches, acts of vandalism, software
viruses, misplaced or lost data, programming or human errors or other similar events which may disrupt our delivery of services or expose
the confidential information of our customers and others. Any security breach involving the misappropriation, loss or other unauthorized
disclosure or use of confidential information of our customers or others, whether by us or a third party, could subject us to civil and
criminal penalties, have a negative impact on our reputation, or expose us to liability to our customers, third parties or government
authorities. We are not aware of such breaches to date. There can be no assurance that we will be able to effectively handle a failure
of our information systems, or that we will be able to restore our operational capacity in a timely manner to avoid disruption to our
business. Any of these developments could have a material adverse effect on our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our obligations in connection with our
senior secured promissory notes could restrict our operating and financial flexibility which could impair our liquidity and thereby harm
our business, results of operations and financial condition.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April&nbsp;3, 2025, the Company issued senior
secured convertible notes (the &ldquo;Initial Notes&rdquo;) having an aggregate principal amount of $5,555,555 for an aggregate purchase
price of $5,000,000 in connection with a securities purchase agreement entered into on March&nbsp;31, 2025 by the Company and certain
institutional investors (the &ldquo;Note SPA&rdquo;). On May&nbsp;19, 2025, the Company issued additional notes having an aggregate principal
amount of $11,111,111 (the &ldquo;Additional Notes&rdquo; and with the Initial Notes, the &ldquo;Notes&rdquo;). The Notes carry a 10%
original issue discount, and mature 18 months from the date of issuance. The Notes are secured by all of the assets of the Company and
the Company&rsquo;s obligation under the Notes are guaranteed by the domestic subsidiaries of the Company and rank senior to all other
existing indebtedness and equity of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Notes, so long as the Notes are
outstanding, the Company is not permitted to among other things, (i)&nbsp;without prior written consent of the holders of the Notes,
to incur any debt, (ii)&nbsp;repurchase, repay, or offer to repay or repurchase more than a de minimis number of shares of Common Stock
or Common Stock Equivalents, or (iii)&nbsp;sell, assign, transfer or otherwise dispose of any of its assets, in each case subject to
limited exceptions. The Notes, while not carrying any interest, include certain events of default which would trigger a 12% default interest
rate that would begin to accrue upon the such an event of default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such limitations on our ability to operate, combined
with our other financial obligations, could increase our vulnerability to adverse changes in general economic, industry and market conditions,
limit our flexibility in planning for, or reacting to, changes in our business and the industry and impose a competitive disadvantage
compared to our competitors that have less debt or are otherwise not subject to similar restrictions on operating.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, because the Notes are secured by
all of our assets, should we default on our obligations under the Notes the holders of such Notes are entitled to the receive the value
of the Notes out of our assets. Such transfer of our assets to the holders of the Notes could result in our ability to continue to operate
our business being severely limited or our inability to continue to operate our business in part or entirely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Future acquisitions may have a material
adverse effect on our ability to manage our business and our results of operations and financial condition.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may acquire businesses, technologies, services,
or products which are complementary to our business. Future acquisitions, such as the currently contemplated acquisition pursuant to
the asset purchase agreement with CompuSystems Inc (the &ldquo;CSI Agreement&rdquo;), may expose us to potential risks, including risks
associated with&nbsp;the integration of new operations, services, and personnel, unforeseen or hidden liabilities, the diversion of resources
and management attention from our existing business and technology, our potential inability to generate sufficient revenue to offset
new costs, the costs and expenses incurred in connection with such acquisitions, or the potential loss of or harm to relationships with
suppliers, employees, and customers resulting from our integration of new businesses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any of the potential risks listed above could
have a material adverse effect on our ability to manage our business or our results of operations and financial condition. In addition,
we may need to fund any such acquisitions through the incurrence of additional debt or the sale of additional debt or equity securities,
which would result in increased debt service obligations, including additional operating and financing covenants, or liens on our assets,
that would restrict our operations, or dilution to our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes in financial accounting standards
may cause adverse and unexpected revenue fluctuations and impact our reported results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A change in accounting standards or practices
could harm our operating results and may even affect our reporting of transactions completed before the change is effective. New accounting
pronouncements and varying interpretations of accounting pronouncements have occurred and may occur in the future. Changes to existing
rules&nbsp;or the questioning of current practices may harm our operating results or the way we conduct our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Climate change may have a long-term impact
on our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Climate change may have an increasingly adverse
impact on our business and those of our customers and suppliers. Water and energy availability and reliability in the communities where
we conduct business is critical. Climate change, its impact on our supply chain and critical infrastructure worldwide, and its potential
to increase political instability in regions where we, our customers and suppliers do business, may disrupt our business and may cause
us to experience higher attrition, losses and costs to maintain or resume operations. Although we maintain a program of insurance coverage
for a variety of property, casualty, and other risks, the types and amounts of insurance we obtain vary depending on availability and
cost. Some of our policies have large deductibles and broad exclusions, and our insurance providers may be unable or unwilling to pay
a claim. Losses not covered by insurance may be large, which could harm our results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations, products and services, as well
as those of our suppliers and customers, may also be subject to climate-related laws, regulations and lawsuits. Regulations such as carbon
taxes, fuel or energy taxes, and pollution limits could result in greater direct costs, including costs associated with changes to manufacturing
processes or the procurement of raw materials used in manufacturing processes, increased levels of capital expenditures to improve facilities
and equipment, and higher compliance and energy costs to reduce emissions, as well as greater indirect costs resulting from our customers,
suppliers or both incurring additional compliance costs that are passed on to us. These costs and restrictions could harm our business
and results of operations by increasing our expenses or requiring us to alter our operations and product design activities. Stockholder
groups may find us insufficiently responsive to the implications of climate change, and therefore we may face legal action or reputational
harm. We may also experience contractual disputes due to supply chain delays arising from climate change-related disruptions, which could
result in increased litigation and costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also face risks related to business trends
that may be influenced by climate change concerns. Stockholder advocacy groups, certain institutional investors, investment funds, other
market participants, stockholders and customers have focused increasingly on the environmental, social and corporate governance (&ldquo;ESG&rdquo;),
and sustainability practices of companies, including those associated with climate change and human rights. These parties have placed
increased importance on the implications of the social cost of their investments. If our ESG practices do not meet stockholder or other
industry expectations and standards, which continue to evolve, our brand, reputation and business activities may be negatively impacted.
Any sustainability disclosures we make may include our policies and practices on a variety of social and ethical matters, including corporate
governance, environmental compliance, employee health and safety practices, human capital management, product quality, supply chain management,
and talent diversity and inclusion practices. It is possible that our stockholders may not be satisfied with our ESG practices or the
speed of their adoption. We could also incur additional costs and require additional resources to monitor, report, and comply with various
ESG practices, or choose not to conduct business with potential customers, or discontinue or not expand business with existing customers,
due to our policies. Also, our failure, or perceived failure, to meet the standards included in any sustainability disclosure could have
a material negative impact on our reputation and business activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We face intense competition in our industry,
and we may not be able to compete successfully in our target markets.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The digital audio, consumer electronics and entertainment
markets are characterized by intense competition, subject to rapid change, and are significantly affected by new product introductions
and other market activities of industry participants. Our competitors include many large domestic and international companies that have
substantially greater financial, technical, marketing, distribution and other resources, greater name recognition, a longer operating
history, broader product lines, lower cost structures and longer-standing relationships with customers and suppliers than we do. As a
result, our competitors may be able to respond better to new or emerging technologies or standards and to changes in customer requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, some of our competitors are in a better
financial and marketing position from which to influence industry acceptance of a particular product standard or a competing technology
than we are. Our competitors may also be able to devote greater resources to the development, promotion and sale of products, and may
be in a position to deliver competitive products at a lower price than we can, along with the potential to conduct strategic acquisitions,
joint ventures, subsidies and lobbying industry and government standards, hire more experienced technicians, engineers and research and
development teams than we can. As a result, we may not be able to compete effectively against any of these organizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to compete in our current target
markets and future markets will depend in large part on our ability to successfully develop, introduce and sell new and enhanced products
or technologies on a timely and cost-effective basis and to respond to changing market requirements. We expect our competitors to continue
to improve the performance of their current products and potentially reduce their prices. In addition, our competitors may develop future
generations and enhancements of competitive products or new or enhanced technologies that may offer greater performance and improved
pricing or render our technologies obsolete. If we are unable to match or exceed the improvements made by our competitors, our market
position and prospects could deteriorate and our net product sales could decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to Our Intellectual Property</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Failure to protect our intellectual property
rights could adversely affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our success depends, in part, on our ability
to protect proprietary methods and technologies that we develop or license under patent and other intellectual property (&ldquo;IP&rdquo;)
laws of the United States, so that we can prevent others from using our inventions and proprietary information. If we fail to protect
our IP rights adequately, our competitors might gain access to our technology, and our business might be adversely affected. However,
defending our IP rights might entail significant expenses. Any of our patent rights, copyrights, trademarks or other IP rights may be
challenged by others, weakened or invalidated through administrative process or litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March&nbsp;31, 2025, we had 25 issued and
36 pending U.S. patents covering our technology. We also license issued U.S. patents from others. The patents that we own or license
from others (including those that may be issued in the future) may not provide us with any competitive advantages or may be challenged
by third parties, and our patent applications may never be granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the process of obtaining patent
protection is expensive and time-consuming, and we may not be able to prosecute all necessary or desirable patent applications at a reasonable
cost or in a timely manner. Even if issued, there can be no assurance that these patents will adequately protect our IP, as the legal
standards relating to the validity, enforceability and scope of protection of patent and other IP rights are uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any patents that are issued may subsequently
be invalidated or otherwise limited, allowing other companies to develop offerings that compete with ours, which could adversely affect
our competitive business position, business prospects and financial condition. In addition, issuance of a patent does not guarantee that
we have a right to practice the patented invention. Patent applications in the United States are typically not published until 18 months
after filing or, in some cases, not at all, and publications of discoveries in industry-related literature lag behind actual discoveries.
We cannot be certain that third parties do not have blocking patents that could be used to prevent us from marketing or practicing our
patented software or technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective patent, trademark, copyright and trade
secret protection may not be available to us in every country in which our software is available. The laws of some foreign countries
may not be as protective of IP rights as those in the United States (in particular, some foreign jurisdictions do not permit patent protection
for software), and mechanisms for enforcement of IP rights may be inadequate. Additional uncertainty may result from changes to IP legislation
enacted in the United States, including the recent America Invents Act, and other national governments and from interpretations of the
IP laws of the United States and other countries by applicable courts and agencies. Accordingly, despite our efforts, we may be unable
to prevent third parties from infringing upon or misappropriating our IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We rely in part on trade secrets, proprietary
know-how and other confidential information to maintain our competitive position. Although we endeavor to enter into non-disclosure agreements
with our employees, licensees and others who may have access to this information, we cannot assure you that these agreements or other
steps we have taken will prevent unauthorized use, disclosure or reverse engineering of our technology. Moreover, third parties may independently
develop technologies or products that compete with ours, and we may be unable to prevent this competition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We might be required to spend significant resources
to monitor and protect our IP rights. We may initiate claims or litigation against third parties for infringement of our proprietary
rights or to establish the validity of our proprietary rights. Litigation also puts our patents at risk of being invalidated or interpreted
narrowly and our patent applications at risk of not issuing. Additionally, we may provoke third parties to assert counterclaims against
us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially viable.
Any litigation, whether or not resolved in our favor, could result in significant expense to us and divert the efforts of our technical
and management personnel, which may adversely affect our business, operating results, financial condition and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be subject to IP rights claims by
third parties, which are extremely costly to defend, could require us to pay significant damages and could limit our ability to use certain
technologies.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Companies in the software and technology industries,
including some of our current and potential competitors, own large numbers of patents, copyrights, trademarks and trade secrets and frequently
enter into litigation based on allegations of infringement or other violations of IP rights. In addition, many of these companies have
the capability to dedicate substantially greater resources to enforce their IP rights and to defend claims that may be brought against
them. The litigation may involve patent holding companies or other adverse patent owners that have no relevant product revenues and against
which our patents may therefore provide little or no deterrence. We have received, and may in the future receive, notices that claim
we have misappropriated, misused, or infringed other parties&rsquo; IP rights, and, to the extent we gain greater market visibility,
we face a higher risk of being the subject of IP infringement claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There may be third-party IP rights, including
issued or pending patents that cover significant aspects of our technologies or business methods. Any IP claims, with or without merit,
could be very time-consuming, could be expensive to settle or litigate and could divert our management&rsquo;s attention and other resources.
These claims could also subject us to significant liability for damages, potentially including treble damages if we are found to have
willfully infringed patents or copyrights. These claims could also result in our having to stop using technology found to be in violation
of a third party&rsquo;s rights. We might be required to seek a license for the IP, which may not be available on reasonable terms or
at all. Even if a license were available, we could be required to pay significant royalties, which would increase our operating expenses.
As a result, we may be required to develop alternative non-infringing technology, which could require significant effort and expense.
If we cannot license or develop technology for any infringing aspect of our business, we would be forced to limit or stop sales of our
software and may be unable to compete effectively. Any of these results would adversely affect our business, operating results, financial
condition and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to the Asset Purchase</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our ability to successfully operate and
grow business related to the Transferred Assets will be largely dependent upon the efforts of Nathaniel Bradley, who became our Chief
Executive Officer upon closing of the Asset Purchase. The loss of any of such key personnel could negatively impact the business and
operations of the Company and its ability to grow the business related to the Acquired Assets.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December&nbsp;31, 2024, pursuant to an asset
purchase agreement by and between the Company and Data Vault Holdings Inc. (&ldquo;Legacy Datavault&rdquo;) dated as of September&nbsp;4,
2024 (as amended prior to the closing of such transaction, the &ldquo;Asset Purchase Agreement&rdquo;), we completed our previously announced
asset purchase (the &ldquo;Asset Purchase&rdquo;) of information technology assets, certain patents and trademarks (collectively, the
 &ldquo;Acquired Assets&rdquo;) from Legacy Datavault. Our ability to successfully operate and grow business related to the Acquired Assets
following the Asset Purchase will be dependent upon the efforts of Nathaniel Bradley, who became our Chief Executive Officer upon consummation
of the Asset Purchase. Although we expect Nathaniel Bradley to remain with the Company, it is possible that we will lose some key personnel,
and the loss of their services could have a material, adverse effect on the business and operations the Company or the ability to grow
the Company&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Acquired Assets could suffer disruptions,
outages, defects, and other performance and quality problems with its platform or with the public cloud and internet infrastructure on
which it relies.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Legacy Datavault&rsquo;s business depends on
our platform to be available without disruption. Legacy Datavault has experienced, and may in the future experience, disruptions, outages,
defects, and other performance and quality problems with Legacy Datavault&rsquo;s platform. Legacy Datavault has also experienced, and
may in the future experience, disruptions, outages, defects, and other performance and quality problems with the public cloud and internet
infrastructure on which Legacy Datavault&rsquo;s platform relies. These problems can be caused by a variety of factors, including introductions
of new functionality, vulnerabilities and defects in proprietary and open source software, human error or misconduct, capacity constraints,
design limitations, or denial of service attacks or other security-related incidents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, if Legacy Datavault&rsquo;s contractual
and other business relationships with Legacy Datavault&rsquo;s public cloud providers are terminated, suspended, or suffer a material
change to which we are unable to adapt, such as the elimination of services or features on which Legacy Datavault&rsquo;s business depends,
we could be unable to provide Legacy Datavault&rsquo;s platform and could experience significant delays and incur additional expense
in transitioning customers to a different public cloud provider.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any disruptions, outages, defects, and other
performance and quality problems with Legacy Datavault&rsquo;s platform or with the public cloud and internet infrastructure on which
it relies, or any material change in Legacy Datavault&rsquo;s contractual and other business relationships with Legacy Datavault&rsquo;s
public cloud providers, could result in reduced use of Legacy Datavault&rsquo;s platform, increased expenses, including service credit
obligations, and harm to the Datavault brand and reputation, any of which could have a material adverse effect on our business, financial
condition, and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If the Asset Purchase&rsquo;s benefits
do not meet the expectations of investors, stockholders or financial analysts, the market price of our securities may decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the benefits of the Asset Purchase after its
closing do not meet the expectations of investors or securities analysts, the market price of our Common Stock may decline. Fluctuations
in the price of our Common Stock could contribute to the loss of all or part of your investment. If an active market for our Common Stock
develops and continues, the trading price of our Common Stock following the Asset Purchase could be volatile and subject to wide fluctuations
in response to various factors, some of which are beyond our control. Any of these factors could have a material adverse effect on your
investment in our Common Stock and our Common Stock may trade at prices significantly below the price you paid for them. In such circumstances,
the trading price of our Common Stock may not recover and may experience a further decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Ownership of Our Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The market price for our Common Stock is
particularly volatile given our status as a relatively unknown company with a small and thinly traded public float, and lack of profits,
which could lead to wide fluctuations in our share price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for our Common Stock is characterized
by significant price volatility when compared to the shares of larger, more established companies that have large public floats, and
we expect that our share price will continue to be more volatile than the shares of such larger, more established companies for the indefinite
future, although such fluctuations may not reflect a material change to our financial condition or operations during any such period.
Such volatility can be attributable to a number of factors. For example, from January&nbsp;1, 2021 through December&nbsp;31, 2021 the
reported sale price of our Common Stock fluctuated between $18,890.55 and $73,163.42 per share. From January&nbsp;1, 2022 through December&nbsp;31,
2022 the reported sale price of our Common Stock fluctuated between $1,293.85 and $21,139.43 per share. From January&nbsp;1, 2023 through
December&nbsp;31, 2023 the reported closing price of our Common Stock has fluctuated between $15.95 and $2,400.30 per share. From January&nbsp;1,
2024 through March&nbsp;31, 2025, the reported sale price of our Common Stock fluctuated between $0.72 and $18.10 per share. Such volatility
can be attributable to a number of factors. First, as noted above, our Common Stock is, compared to the shares of such larger, more established
companies, sporadically and thinly traded. The price for our Common Stock could, for example, decline precipitously in the event that
a large number of our shares are sold on the market without commensurate demand. Secondly, we are a speculative or &ldquo;risky&rdquo;
investment due to our lack of profits to date. As a consequence of this enhanced risk, more risk-adverse investors may, under the fear
of losing all or most of their investment in the event of negative news or lack of progress, be more inclined to sell their shares on
the market more quickly and at greater discounts than would be the case with the stock of a larger, more established company that has
a large public float. Many of these factors are beyond our control and may decrease the market price of our Common Stock regardless of
our operating performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to being highly volatile, our Common
Stock could be subject to wide fluctuations in response to a number of factors that are beyond our control, including, but not limited
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations in our revenues and operating expenses;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated changes
    in the estimates of our operating results or changes in stock market analyst recommendations regarding our Common Stock, other comparable
    companies or our industry generally;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market conditions in our industry, the industries of
    our customers and the economy as a whole;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or expected changes in our growth rates or our
    competitors&rsquo; growth rates;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments in the financial markets and worldwide
    or regional economies;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements of innovations or new products or services
    by us or our competitors;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements by the government relating to regulations
    that govern our industry;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales of our Common Stock or other securities by us
    or in the open market;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in the market valuations of other comparable
    companies; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other events or factors,
    many of which are beyond our control, including those resulting from such events, or the prospect of such events, including war,
    terrorism and other international conflicts, public health issues including health epidemics or pandemics, such as the COVID-19 pandemic,
    and natural disasters such as fire, hurricanes, earthquakes, tornados or other adverse weather and climate conditions, whether occurring
    in the United States or elsewhere, could disrupt our operations, disrupt the operations of our suppliers or result in political or
    economic instability.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if the market for technology stocks
or the stock market in general experiences loss of investor confidence, the trading price of our Common Stock could decline for reasons
unrelated to our business, financial condition or operating results. The trading price of our Common Stock could also decline in reaction
to events that affect other companies in our industry, even if these events do not directly affect us. Each of these factors, among others,
could harm the value of our Common Stock. In the past, following periods of volatility in the market, securities class-action litigation
has often been instituted against companies. Such litigation, if instituted against us, could result in substantial costs and diversion
of management&rsquo;s attention and resources, which could materially and adversely affect our business, operating results and financial
condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If securities or industry analysts do not
publish research or reports about our business, or publish negative reports about our business, our Common Stock price and trading volume
could decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading market for our Common Stock may depend
in part on the research and reports that securities or industry analysts may publish about us or our business, our market and our competitors.
We do not have any control over such analysts. If one or more such analysts downgrade or publish a negative opinion of our Common Stock,
the Common Stock price would likely decline. If analysts do not cover us or do not regularly publish reports on us, we may not be able
to attain visibility in the financial markets, which could have a negative impact on our Common Stock price or trading volume.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>In the event that our Common Stock is delisted
from Nasdaq, U.S. broker-dealers may be discouraged from effecting transactions in shares of our Common Stock because they may be considered
penny stocks and thus be subject to the penny stock rules.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC has adopted a number of rules&nbsp;to
regulate &ldquo;penny stock&rdquo; that restricts transactions involving stock which is deemed to be penny stock. Such rules&nbsp;include
Rules&nbsp;3a51-1, 15g-1, 15g-2, 15g-3, 15g-4, 15g-5, 15g-6, 15g-7, and 15g-9 under the Securities Exchange Act of 1934, as amended.
These rules&nbsp;may have the effect of reducing the liquidity of penny stocks. &ldquo;Penny stocks&rdquo; generally are equity securities
with a price of less than $5.00 per share (other than securities registered on certain national securities exchanges or quoted on Nasdaq
if current price and volume information with respect to transactions in such securities is provided by the exchange or system). Our shares
of Common Stock have in the past constituted, and may again in the future constitute, &ldquo;penny stock&rdquo; within the meaning of
the rules. The additional sales practice and disclosure requirements imposed upon U.S. broker-dealers for sales of penny stocks may discourage
such broker-dealers from effecting transactions in shares of our Common Stock, which could severely limit the market liquidity of such
shares of Common Stock and impede their sale in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A U.S. broker-dealer selling penny stock to anyone
other than an established customer or &ldquo;accredited investor&rdquo; (generally, an individual with a net worth in excess of $1,000,000
or an annual income exceeding $200,000, or $300,000 together with his or her spouse) must make a special suitability determination for
the purchaser and must receive the purchaser&rsquo;s written consent to the transaction prior to sale, unless the broker-dealer or the
transaction is otherwise exempt. In addition, the &ldquo;penny stock&rdquo; regulations require the U.S. broker-dealer to deliver, prior
to any transaction involving a &ldquo;penny stock&rdquo;, a disclosure schedule prepared in accordance with SEC standards relating to
the &ldquo;penny stock&rdquo; market, unless the broker-dealer or the transaction is otherwise exempt. A U.S. broker-dealer is also required
to disclose commissions payable to the U.S. broker-dealer and the registered representative and current quotations for the securities.
Finally, a U.S. broker-dealer is required to submit monthly statements disclosing recent price information with respect to the &ldquo;penny
stock&rdquo; held in a customer&rsquo;s account and information with respect to the limited market in &ldquo;penny stocks&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders should be aware that, according
to the SEC, the market for &ldquo;penny stocks&rdquo; has suffered in recent years from patterns of fraud and abuse. Such patterns include
(i)&nbsp;control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii)&nbsp;manipulation
of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii)&nbsp;&ldquo;boiler room&rdquo;
practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (iv)&nbsp;excessive
and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v)&nbsp;the wholesale dumping of the same securities
by promoters and broker-dealers after prices have been manipulated to a desired level, resulting in investor losses. Our management is
aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate
the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical
limitations to prevent the described patterns from being established with respect to our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You may experience future dilution as a
result of future equity offerings and other issuances of our Common Stock or other securities. In addition, this offering and future
equity offerings and other issuances of our Common Stock or other securities may adversely affect our Common Stock price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to raise additional capital, we may
in the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock at
prices that may not be the same as the price per share in this offering. We may not be able to sell shares or other securities in any
other offering at a price per share that is equal to or greater than the price per share paid by the investor in this offering, and investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which
we sell additional shares of our Common Stock or securities convertible into Common Stock in future transactions may be higher or lower
than the price per share in this offering. You will incur dilution upon exercise of any outstanding stock options, warrants or upon the
issuance of shares of Common Stock under our stock incentive programs. In addition, the sale of shares in this offering and any future
sales of a substantial number of shares of our Common Stock in the public market, or the perception that such sales may occur, could
adversely affect the price of our Common Stock. We cannot predict the effect, if any, that market sales of those shares of Common Stock
or the availability of those shares for sale will have on the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We do not intend to pay dividends on shares
of our Common Stock for the foreseeable future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have never declared or paid any cash dividends
on shares of our Common Stock and do not intend to pay any cash dividends in the foreseeable future. We anticipate that we will retain
all of our future earnings for use in the development of our business and for general corporate purposes. Any determination to pay dividends
in the future will be at the discretion of our board of directors (the &ldquo;Board&rdquo;). Accordingly, investors must rely on sales
of their Common Stock after price appreciation, which may never occur, as the only way to realize any future gains on their investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We could issue &ldquo;blank check&rdquo;
preferred stock without stockholder approval with the effect of diluting then current stockholder interests and impairing their voting
rights; and provisions in our charter documents could discourage a takeover that stockholders may consider favorable.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Certificate of Incorporation authorizes the
issuance of &ldquo;blank check&rdquo; preferred stock with designations, rights and preferences as may be determined from time to time
by the Board. The Board is empowered, without stockholder approval, to issue a series of preferred stock with dividend, liquidation,
conversion, voting or other rights which could dilute the interest of, or impair the voting power of, our common stockholders. The issuance
of a series of preferred stock could be used as a method of discouraging, delaying or preventing a change in control. For example, it
would be possible for the Board to issue preferred stock with voting or other rights or preferences that could impede the success of
any attempt to change control of our Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Series&nbsp;B Preferred Stock has a
liquidation preference over our Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this prospectus, we have 1,750
Series&nbsp;B Preferred Warrants outstanding, each exercisable for one share of Series&nbsp;B Preferred Stock. The Series&nbsp;B Preferred
Stock has a liquidation preference that gets paid prior to any payment on our Common Stock. As a result, if we were to liquidate, dissolve
or wind-up, each holder of our Series&nbsp;B Preferred Stock would have the right to receive payment out of our assets available for
distribution, before any amount is paid to the holders of our Common Stock, in an amount equal in cash to 100% of the stated value of
all shares of Series&nbsp;B Preferred Stock held by such holder, plus any other fees then due and owing thereon, and no more, and if
the assets of the Company shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders
of Series&nbsp;B Preferred Stock shall be ratably distributed among such holders in accordance with the respective amounts that would
be payable on such shares if all amounts payable thereon were paid in full. The payment of the liquidation preferences on the Series&nbsp;B
Preferred Stock could result in holders of our Common Stock not receiving any proceeds if we were to liquidate, dissolve or wind up,
either voluntarily or involuntarily.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The existence of the liquidation preferences
may reduce the value of our Common Stock, make it harder for us to sell shares of Common Stock in offerings in the future, or prevent
or delay a change of control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General Risk Factors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Economic uncertainties or downturns, or
political changes, in the United States and globally, could limit the availability of funds available to our customers and potential
customers, which could materially adversely affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our results of operations could be adversely
affected by general conditions in the economy and financial markets, both in the U.S. and globally, including conditions that are outside
of our control, such as the continuing uncertainty regarding changes to tariffs and the duration and scope of the COVID-19 pandemic,
global supply chain disruptions, the recent inflation in the United States and the foreign and domestic government sanctions imposed
on Russia as a result of its recent invasion of Ukraine. There continues to be volatility and disruptions in the capital and credit markets,
and a severe or prolonged economic downturn, including, but not limited to as a result of such events, could result in a variety of risks
to our business, including weakened demand for our products and our ability to raise additional capital when needed on acceptable terms,
if at all. A weak or declining economy could strain our suppliers, possibly resulting in supply disruption, or cause delays in payments
for our services. In turn, we may be required to increase our allowance for doubtful accounts, which would adversely affect our financial
results. Any of the foregoing could harm our business and we cannot anticipate all the ways in which the current economic climate and
financial market conditions could adversely impact our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes in government trade policies, including
the imposition of tariffs and export restrictions, could have an adverse impact on our business operations and sales.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The United States or foreign governments may
enact changes in government trade policies that could adversely impact our ability to sell products in certain countries, particularly
in China. For example, the U.S. government has imposed tariffs on certain Chinese imports and, in return, the Chinese government has
imposed or proposed tariffs on certain U.S. products. Additionally, export restrictions imposed by the U.S. government, including the
addition of licensing requirements by the United States Department of Commerce&rsquo;s Bureau of Industry and Security (&ldquo;BIS&rdquo;)
through the addition of companies to the BIS Entity List, may require us to suspend our business with certain international customers
if we conclude or are notified by the U.S. government that such business presents a risk of noncompliance with U.S. regulations. We cannot
predict what actions may ultimately be taken with respect to tariffs or trade relations between certain countries, what products may
be subject to such actions, or what actions may be taken by other countries in response. It also may not be possible to anticipate the
timing or duration of such tariffs, export restrictions, or other regulatory actions. These government trade policies may materially
adversely affect our sales and operations with current customers as well as impede our ability to develop relationships with new customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is a risk of further escalation and retaliatory
actions between the U.S. and other foreign governments. If significant tariffs or other restrictions are placed on goods exported from
China or any related counter-measures are taken, our revenue and results of operations may be materially harmed. These tariffs may also
make our customers&rsquo; products more expensive for consumers, which may reduce consumer demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is also a risk that the U.S. government
may seek to implement more protective trade measures, not just with respect to China but with respect to other countries as well, such
as those imposed on Russia in connection with its recent invasion of Ukraine. This could include new or higher tariffs and even more
restrictive trade barriers, such as prohibiting certain types of, or all sales of certain products or products sold by certain parties
into the U.S. Any increased trade barriers or restrictions on global trade could have a materially adverse impact on our business and
financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>A decline in discretionary consumer spending
may adversely affect our industry, our operations and ultimately our profitability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Luxury products, such as speaker systems, TVs,
game consoles and PCs, are discretionary purchases for consumers. Any reduction in consumer discretionary spending or disposable income
may affect our industry significantly. Many economic factors outside of our control could affect consumer discretionary spending, including
the financial markets, consumer credit availability, prevailing interest rates, energy costs, employment levels, salary levels, and tax
rates. Any reduction in discretionary consumer spending could materially adversely affect our business and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Consumer spending weakness could impact
our revenue.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Weakness in general economic conditions may suppress
consumer demand in our markets. Many of the products in which our technologies are incorporated are discretionary goods, such as home-theater
systems. Weakness in general economic conditions may also lead to customers becoming delinquent on their obligations to us or being unable
to pay, resulting in a higher level of write-offs. Economic conditions may impact the amount businesses spend on their speaker systems.
Weakness in economic conditions could lessen demand for our products and negatively affect our revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we are unable to attract, integrate
and retain additional qualified personnel, including top technical talent, our business could be adversely affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our future success depends in part on our ability
to identify, attract, integrate and retain highly skilled technical, managerial, sales and other personnel. We face intense competition
for qualified individuals from numerous other companies, including other software and technology companies, many of whom have greater
financial and other resources than we do. Some of these characteristics may be more appealing to high-quality candidates than those we
have to offer. In addition, new hires often require significant training and, in many cases, take significant time before they achieve
full productivity. We may incur significant costs to attract and retain qualified personnel, including significant expenditures related
to salaries and benefits and compensation expenses related to equity awards, and we may lose new employees to our competitors or other
companies before we realize the benefit of our investment in recruiting and training them. Moreover, new employees may not be or become
as productive as we expect, as we may face challenges in adequately or appropriately integrating them into our workforce and culture.
If we are unable to attract, integrate and retain suitably qualified individuals who are capable of meeting our growing technical, operational
and managerial requirements, on a timely basis or at all, our business will be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Volatility or lack of positive performance in
our share price may also affect our ability to attract and retain our key employees. Many of our senior management personnel and other
key employees have become, or will soon become, vested in a substantial amount of shares of Common Stock, restricted stock units or warrants
to purchase Common Stock. Employees may be more likely to leave us if the shares they own or the shares underlying their vested units
or warrants have significantly appreciated in value relative to the original grant prices of the shares or units or the exercise prices
of the warrants, or, conversely, if the exercise prices of the warrants that they hold are significantly above the market price of our
Common Stock. If we are unable to appropriately incentivize and retain our employees through equity compensation, or if we need to increase
our compensation expenses in order to appropriately incentivize and retain our employees, our business, operating results and financial
condition would be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be subject to litigation for a variety
of claims, which could adversely affect our results of operations, harm our reputation or otherwise negatively impact our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be subject to litigation for a variety
of claims arising from our normal business activities. These may include claims, suits, and proceedings involving labor and employment,
wage and hour, commercial and other matters. The outcome of any litigation, regardless of its merits, is inherently uncertain. Any claims
and lawsuits, and the disposition of such claims and lawsuits, could be time-consuming and expensive to resolve, divert management attention
and resources, and lead to attempts on the part of other parties to pursue similar claims. Any adverse determination related to litigation
could adversely affect our results of operations, harm our reputation or otherwise negatively impact our business. In addition, depending
on the nature and timing of any such dispute, a resolution of a legal matter could materially affect our future operating results, our
cash flows or both.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The requirements of being a U.S. public
company may strain our resources and divert management&rsquo;s attention.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a U.S. public company, we are subject to the
reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Act, the listing requirements of Nasdaq, and other
applicable securities rules&nbsp;and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Compliance with these rules&nbsp;and regulations
increases our legal and financial compliance costs, makes some activities more difficult, time-consuming, or costly, and increases demand
on our systems and resources. The Exchange Act requires, among other things, that we file annual and current reports with respect to
our business and operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_005"></A><FONT STYLE="text-transform: uppercase"><B>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the applicable
prospectus supplement, we intend to use the net proceeds from the sale of the securities offered by this prospectus for general corporate
purposes, which may include, among other things, working capital, capital expenditures, product development, marketing activities, acquisitions
of new technologies and investments, repayment of debt and repurchases and redemptions of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The intended application of proceeds from the
sale of any particular offering of securities using this prospectus will be described in the accompanying prospectus supplement relating
to such offering. The precise amount and timing of the application of these proceeds will depend on our funding requirements and the
availability and costs of other funds. Accordingly, we will retain broad discretion over the use of such proceeds. Pending use of the
net proceeds, we intend to invest the net proceeds in short-term, investment-grade, interest-bearing instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_006"></A><FONT STYLE="text-transform: uppercase"><B>THE
SECURITIES THAT WE MAY&nbsp;OFFER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The descriptions of the securities contained
in this prospectus, together with the applicable prospectus supplements, summarize all of the material terms and provisions of the various
types of securities that we may offer. We will describe in the applicable prospectus supplement relating to any securities the particular
terms of the securities offered by that prospectus supplement. If we indicate in the applicable prospectus supplement, the terms of such
securities may differ from the terms that we have summarized below. We will also include in the prospectus supplement information, where
applicable, about material United States federal income tax considerations relating to the securities, and the securities exchange, if
any, on which such securities will be listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may sell from time to time, in one or more
offerings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our preferred stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase shares of our common stock, preferred
    stock or debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rights to purchase shares of our common stock, preferred
    stock or other securities; and/or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">units consisting of any of the securities listed above.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of any securities that we offer will
be determined at the time of sale. We may issue securities that are exchangeable or exercisable for common stock or any of the other
securities that may be sold under this prospectus. When particular securities are offered, a supplement to this prospectus will be filed
with the SEC, which will describe the terms of the offering and sale of such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_007"></A><FONT STYLE="text-transform: uppercase"><B>DESCRIPTION
OF CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following description of our capital stock,
together with the additional information we include in any applicable prospectus supplement, summarizes the material terms and provisions
of the capital stock that we may offer under this prospectus, but is not complete. For the complete terms of our capital stock, please
refer to our certificate of incorporation, as amended from time to time, any certificate of designation for our preferred stock, and
our bylaws, as amended from time to time. The General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;) may also affect
the terms of our capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Authorized Capital Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is authorized to issue 320,000,000
shares of its capital stock consisting of (a)&nbsp;300,000,000 shares of common stock, par value $0.0001 per share, and (b)&nbsp;20,000,000
shares of &ldquo;blank check&rdquo; preferred stock, par value $0.0001 per share. As of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock were issued and outstanding and no shares of
our preferred stock were issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The description of our common stock is incorporated
by reference to Exhibit&nbsp;4.2&nbsp;to our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm">Annual
Report on Form&nbsp;10-K&nbsp;for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on March&nbsp;31, 2025.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>General</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are authorized to issue up to 20,000,000 shares
of &ldquo;blank check&rdquo; preferred stock, par value $0.0001 per share, none of which are issued and outstanding. Our board of directors
has the authority, without further action by our stockholders, to issue shares of preferred stock in one or more series, to establish
from time to time the number of shares to be included in each such series, to fix the rights, preferences and privileges of the shares
of each wholly unissued series and any qualifications, limitations or restrictions thereon, and to increase or decrease the number of
shares any such series, but not below the number of shares of such series then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors may authorize the issuance
of shares of preferred stock with dividend, liquidation, voting, conversion or other rights that could adversely affect the voting power
or other rights of the holders of our common stock. The purpose of authorizing our board of directors to issue preferred stock and determine
its rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred
stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things,
have the effect of delaying, deferring or preventing a change in control of us and may adversely affect the market price of our common
stock and the voting and other rights of the holders of our common stock. It is not possible to state the actual effect of the issuance
of any preferred stock on the rights of holders of common stock until the board of directors determines the specific rights attached
to that class of preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Series&nbsp;B Convertible Preferred Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October&nbsp;16, 2023, the Company filed a
Certificate of Designation of Preferences, Rights and Limitations of Series&nbsp;B Convertible Preferred Stock (the &ldquo;Series&nbsp;B
Certificate of Designation&rdquo;) with the Secretary of State of the State of Delaware designating 375,000 shares of the Company&rsquo;s
authorized preferred stock as Series&nbsp;B Preferred Stock, and establishing the powers, preferences and rights of the shares of Series&nbsp;B
Preferred Stock and the qualifications, limitations or restrictions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stated Value.</I> The Series&nbsp;B Preferred
Stock have a stated value equal to $100.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Liquidation Preference</I>. The Series&nbsp;B
Preferred stock have a liquidation preference of $100.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Voting. </I>The Series&nbsp;B Preferred Stock
does not have voting rights, except as required by Delaware law and other limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dividends</I>. Dividends on the Series&nbsp;B
Preferred Stock were paid in-kind (&ldquo;PIK dividends&rdquo;) in additional shares of Series&nbsp;B Preferred Stock based on the stated
value of $100.00 per share at the dividend rate of 20.0% per annum (the &ldquo;Dividend Rate&rdquo;). The PIK dividends were paid to
holders of the Series&nbsp;B Preferred Stock of record at the close of business on October&nbsp;17, 2024, or the one-year anniversary
of the closing of the Offering (the &ldquo;Dividend Record Date&rdquo;). PIK dividends on each share of Series&nbsp;B Preferred Stock
were to be paid three business days after the Dividend Record Date in additional fully paid and nonassessable, registered shares of Series&nbsp;B
Preferred Stock in a number equal to the quotient obtained by dividing (A)&nbsp;the product obtained by multiplying (i)&nbsp;the Dividend
Rate and (ii)&nbsp;the stated value of $100.00 per share, by (B)&nbsp;$55.00, the offering price per Unit. The PIK dividends and shares
of Common Stock issuable upon conversion of the PIK dividends were also registered pursuant to the Registration Statement. As of the
Dividend Record Date, no Series&nbsp;B Preferred Stock was outstanding so no PIK dividends were issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Term</I>. The Series&nbsp;B Preferred Stock
has a term of two (2)&nbsp;years. If any shares of Series&nbsp;B Preferred Stock are outstanding at the end of the two (2)&nbsp;year
term, then the Company will promptly redeem all of such outstanding shares of Series&nbsp;B Preferred Stock on a pro rata basis among
all of the holders of Series&nbsp;B Preferred Stock commencing on October&nbsp;17, 2025, in cash at a price per share of Series&nbsp;B
Preferred Stock equal to the sum of (x)&nbsp;100% of the Stated Value plus (y)&nbsp;all accrued and unpaid dividends and (z)&nbsp;all
other amounts due in respect of the Series&nbsp;B Preferred Stock. If, on October&nbsp;17, 2025, the Company is unable to redeem such
outstanding Series&nbsp;B Preferred Stock in cash due to prohibitions under Delaware law, then the Company shall, provided there is no
prohibition under Delaware law, redeem the Series&nbsp;B Preferred Stock by paying to the holders the unpaid cash redemption payment
in duly authorized, validly issued, fully paid and non-assessable shares of Common Stock equal in number to the quotient obtained by
dividing such unpaid amount by the closing price of the Common Stock on the Nasdaq Capital Market on October&nbsp;17, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conversion</I>. The Series&nbsp;B Preferred
Stock are convertible into shares of Common Stock at the option of the holder at any time after issuance at an initial conversion price
per share of $0.4147, which is subject to adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of the Series&nbsp;B Preferred Stock
are prohibited from converting their shares of Series&nbsp;B Preferred Stock to the extent that such conversion would result in the holder
beneficially owning in excess of 4.99% (or, upon election of the holder, 9.99%) of the outstanding shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of July&nbsp;3, 2025, we had warrants to purchase
up to 31,232,173 shares of our common stock outstanding with a weighted average exercise price and remaining life in years of $1.82 and
4.83 years, respectively. The exercise price of such warrants is subject to adjustment upon certain events, such as stock splits, combinations,
dividends, distributions, reclassifications, mergers or other corporate change and dilutive issuances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Anti-Takeover Effects of Provisions of the DGCL and our Certificate
of Incorporation and Bylaws</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Anti-Takeover Statute</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to Section&nbsp;203 of the Delaware
General Corporation Law, which generally prohibits a publicly held Delaware corporation from engaging in any business combination with
any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the
following exceptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">before such date, the board
    of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming
    an interested stockholder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon completion of the
    transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of
    the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting
    stock outstanding, but not the outstanding voting stock owned by the interested stockholder, those shares owned (1)&nbsp;by persons
    who are directors and also officers and (2)&nbsp;employee stock plans in which employee participants do not have the right to determine
    confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on or after such date,
    the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders,
    and not by written consent, by the affirmative vote of at least 66 2&frasl;3% of the outstanding voting stock that is not owned by
    the interested stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, Section&nbsp;203 defines a &ldquo;business
combination&rdquo; to include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any merger or consolidation involving the corporation
    and the interested stockholder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any sale, transfer, pledge or other disposition of
    10% or more of the assets of the corporation involving the interested stockholder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject to certain exceptions,
    any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any transaction involving
    the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation
    beneficially owned by the interested stockholder; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the receipt
    by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through
    the corporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, Section&nbsp;203 defines an &ldquo;interested
stockholder&rdquo; as an entity or person who, together with the person&rsquo;s affiliates and associates, beneficially owns, or within
three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock
of the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Anti-Takeover Effects of Certain Provisions of our Bylaws</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our bylaws provide that directors may be removed
by the stockholders with or without cause upon the vote of a majority of the holders of common stock then entitled to vote. Furthermore,
the authorized number of directors may be changed only by resolution of the board of directors or of the stockholders, and vacancies
may only be filled by a majority vote of the directors, including those who may have resigned. Except as otherwise provided in the bylaws
and the certificate of incorporation, as amended, any vacancies or newly created directorships on the board of directors resulting from
any increase in the authorized number of directors elected by all of the stockholders having the right to vote as a single class may
be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our bylaws also provide that only our chairman
of the board, chief executive officer, president or one or more stockholders holding shares in the aggregate entitled to cast not less
than ten percent of the votes at that meeting may call a special meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The combination of these provisions makes it
more difficult for our existing stockholders to replace our board of directors as well as for another party to obtain control of us by
replacing our board of directors. Since our board of directors has the power to retain and discharge our officers, these provisions could
also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization
of undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or
preferences that could impede the success of any attempt to change our control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These provisions are intended to enhance the
likelihood of continued stability in the composition of our board of directors and its policies and to discourage coercive takeover practices
and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and to discourage certain
tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers
for our shares and may have the effect of delaying changes in our control or management. As a consequence, these provisions may also
inhibit fluctuations in the market price of our common stock that could result from actual or rumored takeover attempts. We believe that
the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent of an unfriendly
or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals, because
negotiation of takeover proposals could result in an improvement of their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Limitation on Directors&rsquo; Liability; Indemnification</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our bylaws contain provisions that limit the
liability of our current and former directors for monetary damages to the fullest extent permitted by Delaware law. Delaware law provides
that directors of a corporation will not be personally liable for monetary damages for any breach of fiduciary duties as directors, except
liability for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any breach of the director&rsquo;s
    duty of loyalty to the corporation or its stockholders;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any act or omission not in
    good faith or that involves intentional misconduct or a knowing violation of law;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unlawful payments of dividends
    or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of the DGCL; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any transaction from which
    the director derived an improper personal benefit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This limitation of liability does not apply to
liabilities arising under federal securities laws and does not affect the availability of equitable remedies such as injunctive relief
or rescission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our bylaws provide that we are required to indemnify
our directors to the fullest extent permitted by Delaware law. Our bylaws also provide that, upon satisfaction of certain conditions,
we are required to advance expenses incurred by a director in advance of the final disposition of any action or proceeding, and permit
us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions
in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under the provisions of Delaware law.
Our bylaws also provide our board of directors with discretion to indemnify our officers and employees when determined appropriate by
our board of directors. We have entered into agreements to indemnify our directors, executive officers and other employees as determined
by the board of directors. With certain exceptions, these agreements provide for indemnification for related expenses including, among
other things, attorneys&rsquo; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding.
We believe that these provisions and agreements are necessary to attract and retain qualified persons as directors and officers. We also
maintain customary directors&rsquo; and officers&rsquo; liability insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The limitation of liability and indemnification
provisions in our bylaws may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty.
They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful,
might benefit us and other stockholders. Further, a stockholder&rsquo;s investment may be adversely affected to the extent that we pay
the costs of settlement and damage awards against directors and officers as required by these indemnification provisions. At present,
there is no pending litigation or proceeding involving any of our directors, officers or employees for which indemnification is sought
and we are not aware of any threatened litigation that may result in claims for indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is traded on Nasdaq under the
symbol &ldquo;DVLT&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent and registrar for our common
stock is VStock Transfer, LLC. The transfer agent&rsquo;s address is 18 Lafayette Place, Woodmere, NY 11598 and its telephone number
is (212) 828-8436.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_008"></A><FONT STYLE="text-transform: uppercase"><B>DESCRIPTION
OF DEBT SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used in this prospectus, the term &ldquo;debt
securities&rdquo; means the debentures, notes, bonds and other evidences of indebtedness that we may issue from time to time. The debt
securities will either be senior debt securities, senior subordinated debt or subordinated debt securities. We may also issue convertible
debt securities. Debt securities may be issued under an indenture (which we refer to herein as an &ldquo;Indenture&rdquo;), which are
contracts entered into between us and a trustee to be named therein. We may issue debt securities and incur additional indebtedness other
than through the offering of debt securities pursuant to this prospectus. It is likely that convertible debt securities will not be issued
under an Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The debt securities may be fully and unconditionally
guaranteed on a secured or unsecured senior or subordinated basis by one or more guarantors, if any. The obligations of any guarantor
under its guarantee will be limited as necessary to prevent that guarantee from constituting a fraudulent conveyance under applicable
law. In the event that any series of debt securities will be subordinated to other indebtedness that we have outstanding or may incur,
the terms of the subordination will be set forth in the prospectus supplement relating to the subordinated debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue debt securities from time to time
in one or more series, in each case with the same or various maturities, at par or at a discount. Unless indicated in a prospectus supplement,
we may issue additional debt securities of a particular series without the consent of the holders of the debt securities of such series
outstanding at the time of the issuance. Any such additional debt securities, together with all other outstanding debt securities of
that series, will constitute a single series of debt securities under the applicable Indenture and will be equal in ranking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Should an Indenture relate to unsecured indebtedness,
in the event of a bankruptcy or other liquidation event involving a distribution of assets to satisfy our outstanding indebtedness or
an event of default under a loan agreement relating to secured indebtedness of our company or its subsidiaries, the holders of such secured
indebtedness, if any, would be entitled to receive payment of principal and interest prior to payments on the unsecured indebtedness
issued under an Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each prospectus supplement will describe the
terms relating to the specific series of debt securities. These terms will include some or all of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the title of debt securities
    and whether the debt securities are senior or subordinated;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any limit on the aggregate
    principal amount of debt securities of such series;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the percentage of the principal
    amount at which the debt securities of any series will be issued;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ability to issue additional
    debt securities of the same series;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the purchase price for the
    debt securities and the denominations of the debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the specific designation of
    the series of debt securities being offered;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the maturity
    date or dates of the debt securities and the date or dates upon which the debt securities are payable and the rate or rates at which
    the debt securities of the series shall bear interest, if any, which may be fixed or variable, or the method by which such rate shall
    be determined;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the basis for calculating interest;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date or dates from which
    any interest will accrue or the method by which such date or dates will be determined;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the duration
    of any deferral period, including the period during which interest payment periods may be extended;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the amount of payments of principal of (and premium, if any) or interest on the debt securities may be determined with reference
    to any index, formula or other method, such as one or more currencies, commodities, equity indices or other indices, and the manner
    of determining the amount of such payments;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the dates
    on which we will pay interest on the debt securities and the regular record date for determining who is entitled to the interest
    payable on any interest payment date;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the place
    or places where the principal of (and premium, if any) and interest on the debt securities will be payable, where any securities
    may be surrendered for registration of transfer, exchange or conversion, as applicable, and notices and demands may be delivered
    to or upon us pursuant to the applicable Indenture;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the rate or rates of amortization
    of the debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any terms for the attachment
    to the debt securities of warrants, options or other rights to purchase or sell our securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the
    debt securities will be secured by any collateral and, if so, a general description of the collateral and the terms and provisions
    of such collateral security, pledge or other agreements;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if we
    possess the option to do so, the periods within which and the prices at which we may redeem the debt securities, in whole or in part,
    pursuant to optional redemption provisions, and the other terms and conditions of any such provisions;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our obligation
    or discretion, if any, to redeem, repay or purchase debt securities by making periodic payments to a sinking fund or through an analogous
    provision or at the option of holders of the debt securities, and the period or periods within which and the price or prices at which
    we will redeem, repay or purchase the debt securities, in whole or in part, pursuant to such obligation, and the other terms and
    conditions of such obligation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms and conditions, if
    any, regarding the option or mandatory conversion or exchange of debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the period
    or periods within which, the price or prices at which and the terms and conditions upon which any debt securities of the series may
    be redeemed, in whole or in part at our option and, if other than by a board resolution, the manner in which any election by us to
    redeem the debt securities shall be evidenced;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any restriction or condition
    on the transferability of the debt securities of a particular series;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the portion,
    or methods of determining the portion, of the principal amount of the debt securities which we must pay upon the acceleration of
    the maturity of the debt securities in connection with any event of default;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the currency
    or currencies in which the debt securities will be denominated and in which principal, any premium and any interest will or may be
    payable or a description of any units based on or relating to a currency or currencies in which the debt securities will be denominated;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provisions,
    if any, granting special rights to holders of the debt securities upon the occurrence of specified events;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any deletions
    from, modifications of or additions to the events of default or our covenants with respect to the applicable series of debt securities,
    and whether or not such events of default or covenants are consistent with those contained in the applicable Indenture;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any limitation on our ability
    to incur debt, redeem stock, sell our assets or other restrictions;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the application,
    if any, of the terms of the applicable Indenture relating to defeasance and covenant defeasance (which terms are described below)
    to the debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">what subordination provisions
    will apply to the debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms, if any, upon which
    the holders may convert or exchange the debt securities into or for our securities or property;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether we are issuing the
    debt securities in whole or in part in global form;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any change
    in the right of the trustee or the requisite holders of debt securities to declare the principal amount thereof due and payable because
    of an event of default;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the depositary for global or
    certificated debt securities, if any;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any material
    federal income tax consequences applicable to the debt securities, including any debt securities denominated and made payable, as
    described in the prospectus supplements, in foreign currencies, or units based on or related to foreign currencies;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any right
    we may have to satisfy, discharge and defease our obligations under the debt securities, or terminate or eliminate restrictive covenants
    or events of default in the Indentures, by depositing money or U.S. government obligations with the trustee of the Indentures;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the names
    of any trustees, depositories, authenticating or paying agents, transfer agents or registrars or other agents with respect to the
    debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to whom
    any interest on any debt security shall be payable, if other than the person in whose name the security is registered, on the record
    date for such interest, the extent to which, or the manner in which, any interest payable on a temporary global debt security will
    be paid;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the
    principal of or any premium or interest on any debt securities is to be payable in one or more currencies or currency units other
    than as stated, the currency, currencies or currency units in which it shall be paid and the periods within and terms and conditions
    upon which such election is to be made and the amounts payable (or the manner in which such amount shall be determined);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the portion
    of the principal amount of any debt securities which shall be payable upon declaration of acceleration of the maturity of the debt
    securities pursuant to the applicable Indenture;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the
    principal amount payable at the stated maturity of any debt security of the series will not be determinable as of any one or more
    dates prior to the stated maturity, the amount which shall be deemed to be the principal amount of such debt securities as of any
    such date for any purpose, including the principal amount thereof which shall be due and payable upon any maturity other than the
    stated maturity or which shall be deemed to be outstanding as of any date prior to the stated maturity (or, in any such case, the
    manner in which such amount deemed to be the principal amount shall be determined); and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other
    specific terms of the debt securities, including any modifications to the events of default under the debt securities and any other
    terms which may be required by or advisable under applicable laws or regulations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the applicable
prospectus supplement, we do not anticipate the debt securities will be listed on any securities exchange. Holders of the debt securities
may present registered debt securities for exchange or transfer in the manner described in the applicable prospectus supplement. Except
as limited by the applicable Indenture, we will provide these services without charge, other than any tax or other governmental charge
payable in connection with the exchange or transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Debt securities may bear interest at a fixed
rate or a variable rate as specified in the prospectus supplement. In addition, if specified in the prospectus supplement, we may sell
debt securities bearing no interest or interest at a rate that at the time of issuance is below the prevailing market rate, or at a discount
below their stated principal amount. We will describe in the applicable prospectus supplement any special federal income tax considerations
applicable to these discounted debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue debt securities with the principal
amount payable on any principal payment date, or the amount of interest payable on any interest payment date, to be determined by referring
to one or more currency exchange rates, commodity prices, equity indices or other factors. Holders of such debt securities may receive
a principal amount on any principal payment date, or interest payments on any interest payment date, that are greater or less than the
amount of principal or interest otherwise payable on such dates, depending upon the value on such dates of applicable currency, commodity,
equity index or other factors. The applicable prospectus supplement will contain information as to how we will determine the amount of
principal or interest payable on any date, as well as the currencies, commodities, equity indices or other factors to which the amount
payable on that date relates and certain additional tax considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_009"></A><FONT STYLE="text-transform: uppercase"><B>DESCRIPTION
OF WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue warrants to purchase shares of our
Common Stock, preferred stock and/or debt securities in one or more series together with other securities or separately, as described
in the applicable prospectus supplement. Below is a description of certain general terms and provisions of the warrants that we may offer.
Particular terms of the warrants will be described in the warrant agreements and the prospectus supplement relating to the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The applicable prospectus supplement will contain,
where applicable, the following terms of and other information relating to the warrants:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the specific designation and
    aggregate number of, and the price at which we will issue, the warrants;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the currency or currency units
    in which the offering price, if any, and the exercise price are payable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the designation, amount and
    terms of the securities purchasable upon exercise of the warrants;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable,
    the exercise price for shares of our Common Stock and the number of shares of Common Stock to be received upon exercise of the warrants;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable,
    the exercise price for shares of our preferred stock, the number of shares of preferred stock to be received upon exercise, and a
    description of that series of our preferred stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable,
    the exercise price for our debt securities, the amount of debt securities to be received upon exercise, and a description of that
    series of debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date
    on which the right to exercise the warrants will begin and the date on which that right will expire or, if you may not continuously
    exercise the warrants throughout that period, the specific date or dates on which you may exercise the warrants;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these
    forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security
    included in that unit;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any applicable material U.S.
    federal income tax consequences;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the identity
    of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other
    agents;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the proposed
    listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable,
    the date from and after which the warrants and the Class&nbsp;A common stock, preferred stock and/or debt securities will be separately
    transferable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable, the minimum
    or maximum amount of the warrants that may be exercised at any one time;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information with respect to
    book-entry procedures, if any;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the anti-dilution provisions
    of the warrants, if any;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any redemption or call provisions;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether the warrants may be
    sold separately or with other securities as parts of units; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any additional
    terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Outstanding Warrants</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of July&nbsp;3, 2025, we had the following warrants outstanding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 43 shares of common stock originally issued in June&nbsp;2020 with a weighted average exercise price of $38,626.74
    per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 3 shares of common stock originally issued on November&nbsp;9, 2020 with a weighted average exercise price of $38,250.00
    per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 1 share of common stock originally issued on December&nbsp;21, 2020 with an exercise price of $39,000.00 per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 16 shares of common stock originally issued on January&nbsp;19, 2021 with a weighted average exercise price of
    $63,000.00 per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 14 shares of common stock originally issued on June&nbsp;8, 2021 with a weighted average exercise price of $66,900.00
    per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 2 shares of common stock originally issued on December&nbsp;16, 2021 each with an exercise price of $22,800.00
    per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 151 shares of common stock originally issued on August&nbsp;15, 2022 with a weighted average exercise price of
    $1,191.42 per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 7,200 shares of common stock originally issued on December&nbsp;1, 2022 with a weighted average exercise price
    of $3.196 per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 5,831 shares of common stock originally issued on February&nbsp;3, 2023 with a weighted average exercise price
    of $1,574.00 per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 4,383,293 shares of common stock originally issued in September&nbsp;2024 with a weighted average exercise price
    of $2.21 per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 65,000 shares of common stock originally issued on November&nbsp;19, 2024 with a weighted average exercise price
    of $2.21 per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 2,186,485 shares of common stock originally issued in December&nbsp;2024 with a weighted average exercise price
    of $1.62 per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 5,232,839 shares of common stock originally issued on February&nbsp;14, 2025 with a weighted average exercise price
    of $1.14 per share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 6,448,700 shares of common stock originally issued on April&nbsp;2, 2025 with a weighted average exercise price
    of $0.862 per share; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">Warrants to purchase up to 12,897,401 shares of common stock originally issued on May&nbsp;19, 2025
    with a weighted average exercise price of $0.862 per share.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_010"></A><FONT STYLE="text-transform: uppercase"><B>DESCRIPTION
OF RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue rights to purchase shares of our
common stock, preferred stock, debt securities or other securities. These rights may be issued independently or together with any other
security offered hereby and may or may not be transferable by the holder receiving the rights in such offering. The applicable prospectus
supplement may add, update or change the terms and conditions of the rights as described in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The applicable prospectus supplement will describe
the specific terms of any offering of rights for which this prospectus is being delivered, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the price, if any, per right;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise price payable
    for common stock, preferred stock or other securities upon the exercise of the rights;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of rights issued
    or to be issued to each holder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number and terms of common
    stock, preferred stock or other securities which may be purchased per right;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the extent to which the rights
    are transferable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other terms of the rights,
    including the terms, procedures and limitations relating to the exchange and exercise of the rights;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the holder&rsquo;s
    ability to exercise the rights shall commence, and the date on which the rights shall expire;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the extent to which the rights
    may include an over-subscription privilege with respect to unsubscribed securities; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable,
    the material terms of any standby underwriting or purchase arrangement entered into by us in connection with the offering of such
    rights.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders may exercise rights as described in the
applicable prospectus supplement. Upon receipt of payment and the rights certificate properly completed and duly executed at the corporate
trust office of the rights agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward
the applicable securities purchased upon exercise of the rights. If less than all of the rights issued in any rights offering are exercised,
we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters or dealers or
through a combination of such methods, including pursuant to standby arrangements with one or more underwriters or other purchasers,
pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such
offering, as described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The description in the applicable prospectus
supplement of any rights that we may offer will not necessarily be complete and will be qualified in its entirety by reference to the
applicable rights certificate, which will be filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_011"></A><FONT STYLE="text-transform: uppercase"><B>DESCRIPTION
OF UNITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue units comprised of one or more of
the other securities described in this prospectus in any combination. Each unit will be issued so that the holder of the unit is also
the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each
included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held
or transferred separately, at any time or at any time before a specified date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may evidence units by unit certificates that
we issue under a separate unit agreement. We may issue the units under a unit agreement between us and one or more unit agents. If we
elect to enter into a unit agreement with a unit agent, the unit agent will act solely as our agent in connection with the units and
will not assume any obligation or relationship of agency or trust for or with any registered holders of units or beneficial owners of
units. We will indicate the name and address and other information regarding the unit agent in the applicable prospectus supplement relating
to a particular series of units if we elect to use a unit agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will describe in the applicable prospectus
supplement the terms of the series of units being offered, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the designation
    and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities
    may be held or transferred separately;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any unit
    agreement under which the units will be issued and any provisions of the unit agreement that differ from those described herein;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any provisions
    for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether the units will be issued
    in fully registered or global form.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The other provisions regarding our common stock,
preferred stock, debt securities, warrants and rights as described in this prospectus will apply to each unit to the extent such unit
consists of shares of our common stock, preferred stock, debt securities, warrants and/or rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_012"></A><FONT STYLE="text-transform: uppercase"><B>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may sell the securities being offered pursuant
to this prospectus from time to time in one or more transactions, including, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through underwriters or dealers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through agents;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">directly by us to purchasers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in a rights offering;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in &ldquo;at
    the market&rdquo; offerings within the meaning of Rule&nbsp;415(a)(4)&nbsp;of the Securities Act to or through a market maker or
    into an existing trading market on an exchange or otherwise;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through a combination of any
    of these methods; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through any other method permitted
    by applicable law and described in a prospectus supplement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The applicable prospectus supplement will describe
the terms of the offering of the securities, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the name or names of any underwriters,
    if any, and if required, any dealers or agents;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the purchase price of the securities
    and the proceeds that we will receive from the sale;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any underwriting discounts
    and other items constituting underwriters&rsquo; compensation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any commissions paid to agents;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any discounts or concessions
    allowed or reallowed or paid to dealers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any delayed delivery arrangements;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any additional risk factors
    applicable to the securities that we propose to sell; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any securities exchange or
    market on which the securities may be listed.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may sell the securities from time to time
in one or more transactions at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a fixed price or prices, which
    may be changed;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market prices prevailing at
    the time of sale;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices related to such prevailing
    market prices; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">negotiated prices.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Sale through Underwriters or Dealers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If underwriters are used in the sale, the underwriters
may resell the securities from time to time in one or more transactions, including negotiated transactions, at a fixed public offering
price or at varying prices determined at the time of sale. Underwriters may offer securities to the public either through underwriting
syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters. Unless we inform
you otherwise in the applicable prospectus supplement, the obligations of the underwriters to purchase the securities will be subject
to certain conditions, and the underwriters will be obligated to purchase all of the offered securities if they purchase any of them.
The underwriters may change from time to time any initial public offering price and any discounts or concessions allowed or reallowed
or paid to dealers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will describe the name or names of any underwriters,
dealers or agents and the purchase price of the securities in a prospectus supplement relating to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the sale of the securities,
underwriters may receive compensation from us or from purchasers of the securities, for whom they may act as agents, in the form of discounts,
concessions or commissions. Underwriters may sell the securities to or through dealers, and these dealers may receive compensation in
the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for whom they may act
as agents, which is not expected to exceed that customary in the types of transactions involved. Underwriters, dealers and agents that
participate in the distribution of the securities may be deemed to be underwriters, and any discounts or commissions they receive from
us and any profit on the resale of the securities they realize may be deemed to be underwriting discounts and commissions under the Securities
Act. The prospectus supplement will identify any underwriter or agent and will describe any compensation they receive from us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Underwriters could make sales in privately negotiated
transactions and/or any other method permitted by law, including sales deemed to be an &ldquo;at-the-market&rdquo; offering, sales made
directly on Nasdaq, or such other exchange or automated quotation system on which our securities trade, or sales made to or through a
market maker other than on an exchange. The name of any such underwriter or agent involved in the offer and sale of our securities, the
amounts underwritten, and the nature of its obligations to take our securities will be described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the prospectus
supplement, each series of the securities will be a new issue with no established trading market, other than our common stock, which
is currently traded on Nasdaq. We may elect to list any of the securities on an exchange, but are not obligated to do so. It is possible
that one or more underwriters may make a market in a series of the securities, but underwriters will not be obligated to do so and may
discontinue any market making at any time without notice. Therefore, we can give no assurance about the liquidity of or the trading market
for any of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In compliance with the guidelines of the Financial
Industry Regulatory Authority,&nbsp;Inc. (&ldquo;FINRA&rdquo;), the maximum aggregate discounts, commissions, agency fees or other items
constituting underwriting compensation to be received by any FINRA member or independent broker-dealer will not exceed 8% of the aggregate
offering price of the securities offered pursuant to this prospectus and any applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To facilitate the offering of securities, certain
persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the securities.
This may include over-allotments or short sales of the securities, which involve the sale by persons participating in the offering of
more securities than we sold to them. In these circumstances, these persons would cover such over-allotments or short positions by making
purchases in the open market or by exercising their over-allotment option, if any. In addition, these persons may stabilize or maintain
the price of the securities by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions
allowed to dealers participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization
transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that
which might otherwise prevail in the open market. These transactions may be discontinued at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we or our affiliates may engage
in transactions with these underwriters, dealers and agents in the ordinary course of business. Underwriters have from time to time in
the past provided, and may from time to time in the future provide, investment banking services to us for which they have in the past
received, and may in the future receive, customary fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Direct Sales and Sales through Agents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may sell the securities directly. In this
case, no underwriters or agents would be involved. We may also sell the securities through agents designated by us from time to time.
In the applicable prospectus supplement, we will name any agent involved in the offer, sale or resale of the offered securities, and
we will describe any commissions payable to the agent. Unless we inform you otherwise in the applicable prospectus supplement, any agent
will agree to use its reasonable best efforts to solicit purchases for the period of its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may sell the securities directly to institutional
investors or others who may be deemed to be underwriters within the meaning of the Securities Act with respect to any sale of those securities.
We will describe the terms of any sales of these securities in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Remarketing Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities may also be offered and sold, if so
indicated in the applicable prospectus supplement, in connection with a remarketing upon their purchase, in accordance with a redemption
or repayment pursuant to their terms, or otherwise, by one or more remarketing firms, acting as principals for their own accounts or
as agents for us. Any remarketing firm will be identified and the terms of its agreements, if any, with us and its compensation will
be described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Delayed Delivery Contracts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we so indicate in the applicable prospectus
supplement, we may authorize agents, underwriters or dealers to solicit offers from certain types of institutions to purchase securities
from us at the public offering price under delayed delivery contracts. Institutions with which we may make these delayed delivery contracts
include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions
and others. These contracts would provide for payment and delivery on a specified date in the future. The contracts would be subject
only to those conditions described in the applicable prospectus supplement. The obligations of any purchaser under any such delayed delivery
contract will be subject to the condition that the purchase of the securities shall not at the time of delivery be prohibited under the
laws of the jurisdiction to which the purchaser is subject. The underwriters and other agents will not have any responsibility with regard
to the validity or performance of these delayed delivery contracts. The applicable prospectus supplement will describe the commission
payable for solicitation of those contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may have agreements with the underwriters,
dealers, agents and remarketing firms to indemnify them against certain civil liabilities, including liabilities under the Securities
Act, or to contribute with respect to payments that the underwriters, dealers, agents or remarketing firms may be required to make. Underwriters,
dealers, agents and remarketing firms may be customers of, engage in transactions with or perform services for us in the ordinary course
of their businesses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_013"></A><FONT STYLE="text-transform: uppercase"><B>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The validity of the issuance of the securities
offered hereby will be passed upon for us by Sullivan&nbsp;&amp;Worcester LLP of New York, New York. Additional legal matters may be
passed upon for us or any underwriters, dealers or agents, by counsel that we will name in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_014"></A><FONT STYLE="text-transform: uppercase"><B>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of Datavault
AI Inc. as of December&nbsp;31, 2024 and 2023 and for each of the two years in the period ended December&nbsp;31, 2024, incorporated
in this prospectus by reference to the <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm">Annual
Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A>, have been so incorporated in reliance on the report (which contains
an explanatory paragraph relating to the Company&rsquo;s ability to continue as a going concern as described in Note 2 to the consolidated
financial statements) of BPM LLP, an independent registered public accounting firm, given on the authority of said firm as experts in
auditing and accounting. The consolidated financial statements of CompuSystems,&nbsp;Inc. for the fiscal years ended December&nbsp;31,
2024 and 2023 incorporated in this prospectus by reference to the <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925061666/tm2518588d1_8ka.htm">Current
Report on Form&nbsp;8-K filed with the SEC on June&nbsp;23, 2025</A>, have been so incorporated in reliance on the report of BG Advisors
CPA,&nbsp;Ltd., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_015"></A><FONT STYLE="text-transform: uppercase"><B>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus constitutes a part of a registration
statement on Form&nbsp;S-3 filed under the Securities Act. As permitted by the SEC&rsquo;s rules, this prospectus and any prospectus
supplement, which form a part of the registration statement, do not contain all the information that is included in the registration
statement. You will find additional information about us in the registration statement and its exhibits. Any statements made in this
prospectus or any prospectus supplement concerning legal documents are not necessarily complete and you should read the documents that
are filed as exhibits to the registration statement or otherwise filed with the SEC for a more complete understanding of the document
or matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You can read our SEC filings, including the registration
statement, over the internet at the SEC&rsquo;s website at www.sec.gov. You may also read and copy any document we file with the SEC
at its public reference facilities at 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of these documents at prescribed
rates by writing to the Public Reference Section&nbsp;of the SEC at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330 for further information on the operation of the public reference facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the information reporting requirements
of the Exchange Act, and we file reports, proxy statements and other information with the SEC. These reports, proxy statements and other
information will be available for inspection and copying at the public reference room and website of the SEC referred to above. We also
maintain a website at <I>www.datavaultsite.com</I>, at which you may access these materials free of charge as soon as reasonably practicable
after they are electronically filed with, or furnished to, the SEC. However, the information contained in or accessible through our website
is not part of this prospectus or the registration statement of which this prospectus forms a part, and investors should not rely on
such information in making a decision to purchase our common stock in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_016"></A><FONT STYLE="text-transform: uppercase"><B>INCORPORATION
OF DOCUMENTS BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC permits us to &ldquo;incorporate by reference&rdquo;
into this prospectus the information contained in documents we file with the SEC, which means that we can disclose important information
to you by referring you to those documents. Information that is incorporated by reference is considered to be part of this prospectus
and you should read it with the same care that you read this prospectus. Information that we file later with the SEC will automatically
update and supersede the information that is either contained, or incorporated by reference, in this prospectus, and will be considered
to be a part of this prospectus from the date those documents are filed. We have filed with the SEC and incorporate by reference in this
prospectus, except as superseded, supplemented or modified by this prospectus, the documents listed below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231x10k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on March&nbsp;31, 2025;</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current
    Reports on Form&nbsp;8-K filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925001395/tm252064d2_8k.htm">January&nbsp;6,
    2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925001736/tm252064d1_8k.htm">January&nbsp;7,
    2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925002022/tm252259d1_8ka.htm">January&nbsp;8,
    2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925012760/tm256455d2_8k.htm">February&nbsp;13,
    2025</A> (the first Current Report on Form&nbsp;8-K filed on such date), <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925012422/tm256455d1_8k.htm">February&nbsp;13,
    2025</A> (the second Current Report on Form&nbsp;8-K filed on such date), <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925014230/tm256656d2_8k.htm">February&nbsp;14,
    2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925019129/tm257883d1_8k.htm">February&nbsp;28,
    2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925024238/tm259436d1_8k.htm">March&nbsp;17, 2025</A>,
    <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925029947/tm2510880d2_8k.htm">March&nbsp;31, 2025</A> (the
    first Current Report on Form&nbsp;8-K filed on such date), <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925029648/tm2510880d1_8k.htm">March&nbsp;31,
    2025</A> (the second Current Report on Form&nbsp;8-K filed on such date), <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925031132/tm2511063d1_8k.htm">April&nbsp;2,
    2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925032260/tm2511578d1_8k.htm">April&nbsp;4, 2025</A>,
    <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925034671/tm2512185d1_8k.htm">April&nbsp;14, 2025</A>,
    <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925046741/tm2514424d1_8k.htm">May&nbsp;9, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925046773/tm2514540d1_8ka.htm">May&nbsp;9,
    2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925049498/tm2515254d1_8k.htm">May&nbsp;15, 2025</A>,
    <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925050650/tm2515584d1_8k.htm">May&nbsp;20, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925051079/tm2515584d2_8k.htm">May&nbsp;20,
    2025</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465925061666/tm2518588d1_8ka.htm">June&nbsp;23,
    2025</A> (except for Item 2.02 and Item 7.01 of any Current Report on Form&nbsp;8-K which are not deemed &ldquo;filed&rdquo; for
    purposes of Section&nbsp;18 of the Exchange Act and are not incorporated by reference in this prospectus); and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description
    of our common stock contained in (i)&nbsp;our registration statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1682149/000114420418039919/tv499143_8-a12b.htm">Form&nbsp;8-A,
    filed with the SEC on July&nbsp;25, 2018</A> under Section&nbsp;12(b)&nbsp;of the Exchange Act, including any amendments or reports
    filed for the purpose of updating such description and (ii)&nbsp;<A HREF="https://www.sec.gov/Archives/edgar/data/1682149/000141057825000600/dvlt-20241231xex4d2.htm">Exhibit&nbsp;4.2</A>&mdash;Description
    of Securities Registered Pursuant to Section&nbsp;12 of the Securities Exchange Act of 1934, to our Annual Report on Form&nbsp;10-K
    for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on March&nbsp;31, 2025.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also incorporate by reference into this prospectus
additional documents that we may file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date hereof
but before the completion or termination of this offering (excluding any information not deemed &ldquo;filed&rdquo; with the SEC). Any
statement contained in a previously filed document is deemed to be modified or superseded for purposes of this prospectus to the extent
that a statement contained in this prospectus or in a subsequently filed document incorporated by reference herein modifies or supersedes
the statement, and any statement contained in this prospectus is deemed to be modified or superseded for purposes of this prospectus
to the extent that a statement contained in a subsequently filed document incorporated by reference herein modifies or supersedes the
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will provide, without charge, to each person
to whom a copy of this prospectus is delivered, including any beneficial owner, upon the written or oral request of such person, a copy
of any or all of the documents incorporated by reference herein, including exhibits. Requests should be directed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Datavault AI&nbsp;Inc.<BR>
15268 NW Greenbrier Pkwy<BR>
Beaverton, OR 97006<BR>
(408) 627-4716<BR>
<U>info@wisatechnologies.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Copies of these filings are also available on
our website at&nbsp;<I>www.datavaultsite.com. </I>For other ways to obtain a copy of these filings, please refer to &ldquo;Where You
Can Find More Information&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59; Options: NewSection; Value: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5,725,907 shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm2529329d1_424b5img002.jpg" ALT="" STYLE="height: 58px; width: 225px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Datavault AI&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prospectus Supplement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">October&nbsp;24, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 61; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2529329d1_424b5img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2529329d1_424b5img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !H 5X# 2(  A$! Q$!_\0
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M1N_"I*\),]$****T **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_4E@\WK9=-Z/5'W9^VQ_P4"^&_\ P3Z^']AXF^)NM'1-*U"X^RP2!-S/)P<
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MCPQ!HJ-/(HM6E1E)RP'"D#KBOL- RX&" /I39(2\K$@X]C2;Z ?E+_P;@_\
M!'[XP?\ !+SQE\5[SXH+H!A\8VFGQV+:;>B8%H2Y8,N!MQN 'TK]3+RS>="
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
/!1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2529329d1_424b5img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2529329d1_424b5img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !> 3<# 2(  A$! Q$!_\0
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MH)YK./4?!L.H6XEC6:*WBN+#5-.(+^=&VYUC3&T*,I249>Y?9VOLTGHW'O\
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MZ5!=2ZA+;W7AKQ'=6H72_$NC7$4I%GK6E.S6NGSD_9EM;HQ3YDBP/ZN?VR/
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MZ6MYW-82YXQE:U^F_P#D=U152"Z67KQD @=?7T ST[#M[U,\\,>-\B+D$C)
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M!I,$\]/_ *] %YY$0@,<$\T)(KYVG.,9_&J*7<2R&,@%L*=N[. =VT\C^(=
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M[3]7\/\ PG_:/LH;A]3T6_D\!:U,D"QF_L;N3^U+1I' 5Y8FEG>Q5]RA8XT
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MCSI;>816DX6;:25S\W/G_P#P1"_X("? O]K/X%']K3]M/_A8/BRU^),E]<^
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M%5O\0/!'Q9LO"[/H'Q*;QU>37IU>Q5[QKR[T*YM[9XDN]31S%%!(YB11N7#
M#^;#_@A]\.?&GPT_X+N^!_AK\4+K4=?^(/@ZZ^+W@SQ%KVL*PN-1L=&L;'1-
M,GN([A9)Y9;C0K2T97=LE98R#P,Q&ES)^]:WE?\ )^70T/[Y/@=_P5+_ &#/
MVB_C+_PS[\&OV@O#_C'XQVS>(+>7P';QZ@VIVTGA"\:UUUYS-:QJILY=T3L\
MF!STR<_9'Q6^+7P[^"/P]\3_ !1^)WBRP\%^!?">G+K?B3Q#JG-OI6FL1&,
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MM)=S*-,T4RS366G6TC*&1+E&BMY8AN6=O*#J"%S_ $G?\$>?V8;GX2_">_\
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M^;4K;0?#Q*7EY=7-\MJNG,H@5(Y6^T/'%*3&Q#A:^ _^"$?@;Q!XT_X(Q?\
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MN@X4C'3ICT\^^&_PZ\,_#3P[;>'?#EHT5C BHOF.6=@&W2%N?OLQ=\+@ $
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MGMT92Q9=ORJ.G7DY/'3W'TJU14'2%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5'(&)4J,X# \@=<>OTJ2B@"OMD_N?^/+3
8T5LY8;>"!R#G)'IZ8_6I:* "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
